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ABSTRACT 
 
 Macrophage inflammatory status governs inflammatory responses in metabolic 
tissues including adipose and liver tissues, and critically contributes to the development 
of diet-induced obesity and systemic insulin resistance. Therefore, regulating 
macrophage proinflammatory or anti-inflammatory activation can help control the diet-
induced inflammation in adipose tissue and systemic insulin resistance. To better 
understand the control of macrophage activation status, circadian clockworks and 
PFKFB3 were investigated in the context of diet-induced inflammation and insulin 
resistance. 
Through in vivo studies of bone marrow-transplanted mice fed with high fat diet 
(HFD) for 12 weeks, and in vitro studies on bone marrow-derived macrophages 
(BMDM) and co-cultures of BMDM and adipocytes, the present study demonstrated that 
disruption of circadian genes Period1 and Period2 in macrophages increases their 
proinflammatory activation, and exacerbates diet-induced inflammation and insulin 
resistance. Through similar research methods, this research showed that PFKFB3 
disruption in macrophages exacerbates diet-induced adipose tissue inflammation and 
insulin resistance. Taken together, both the circadian clock and PFKFB3 were shown to 
be key regulators of macrophage activation, evidenced by that either dysregulation of 
circadian clock or disruption of PFKFB3 contributes to the physiological cascade by 
which diet-induced obesity triggers macrophage proinflammatory activation, adipose 
tissue inflammation, and insulin resistance.  
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NOMENCLATURE 
 
AU  Arbitrary Units 
BMAL1  Brain Muscle ARNT-Like Protein 1 
BMDM  Bone Marrow-Derived Macrophage(s) 
BMT  Bone Marrow Transplantation 
CCG  Clock-Controlled Genes 
CLOCK  Circadian Locomotor Output Cycles Kaput 
Cry  Cryptochrome 
Ctrl  Control  
FAS   Fatty Acid Synthase 
F-2, 6-P2                    Fructose 2,6-bisphosphate 
GTT  Glucose Tolerance Test 
HFD  High Fat Diet 
IL-4  Interleukin-4 
IL-1β  Interleukin-1β 
IL-6  Interleukin-6 
IL-10  Interleukin-10 
iPFK2  Inducible 6-phosphofructo-2-kinase 
ITT  Insulin Tolerance Test 
JNK  c-Jun N-terminal Kinase 
LFD  Low Fat Diet 
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LPS  Lipopolysacharride 
Luc  Luciferase 
MCP-1  Monocyte Chemotactic Protein-1 
NF-κB  Nuclear Factor kB 
Per  Period 
PFK-2/FBPase  6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 
PPAR  Peroxisome Proliferator-activated Receptor 
PPARα  Peroxisome Proliferator-activated Receptor Alpha 
PPARγ  Peroxisome Proliferator-activated Receptor Gamma 
ROS  Reactive Oxygen Species 
RT-PCR  Reverse Transcription Polymerase Chain Reaction 
6PFK1                         6-phosphofructo-1-kinase 
SREBP-1c  Sterol Regulatory Element-Binding Protein 1c 
SVC  Stromal Vascular Cell(s) 
TLR-4  Toll-Like Receptor-4 
TNF α  Tumor Necrosis Factor α 
TZDs  Thiazolidinediones 
WT  Wild-Type 
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1. INTRODUCTION AND LITERATURE REVIEW 
1.1 Introduction 
Over the past decades, research has shown that chronic low-grade inflammation is a 
common characteristic of obesity and a critical contributor to the  development of non-
infectious chronic diseases, such as type II diabetes, cardiovascular disease, and certain 
cancers [1, 2] (Fig. 1). In the process of inflammation, macrophages play a critical role. 
For example, it has been suggested that macrophage inflammatory status is a key 
determinant of systemic insulin resistance [3, 4]. It is well known that macrophage 
inflammatory status is under bi-directional control of macrophage polarization.  On one 
hand, when undergoing classic proinflammatory, or M1 activation, macrophages display 
increased expression of proinflammatory cytokines, such as tumor necrosis factor alpha 
(TNFα) and interleukin-6 (IL-6). On the other hand, when undergoing M2 activation, 
macrophages produce anti-inflammatory factors, such as IL-10 and arginase I, which 
accounts for protection of overnutrition-induced insulin resistance [5-7]. As such, 
elucidating the mechanisms underlying macrophage inflammatory status appears to be a 
key to better understand the pathogenesis of inflammation in the context of systemic 
insulin resistance. 
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Figure 1. Chronic inflammation contributes to chronic diseases. 
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1.2 Literature Review 
1.2.1 Obesity 
Chronic diseases are the leading causes of death in the U.S. based on the 2010 data 
released by the Centers for Disease Control and Prevention. Heart disease, cancer, and 
stroke took the first, second, and fourth positions, respectively, and diabetes mellitus was 
ranked as the seventh leading cause of death [8]. Obesity is a key risk factor for the 
development of most chronic diseases. During obesity, fat accumulation and chronic 
low-grade inflammation interact, resulting in systemic insulin resistance [9]. Recently, 
accumulating evidence pointed out that fat deposition alone may not simply indicate 
insulin resistance. Instead, inflammatory responses in critical metabolic tissues, such as 
adipose and liver, are more important in causing systemic insulin resistance. My 
colleagues in the lab discovered that disruption of iPFK2 exacerbates diet-induced 
systemic insulin resistance and adipose tissue inflammatory response, even though less 
adiposity was observed when compared to HFD-fed WT (C57BL/6J) littermates [10]. It 
appears that controlling of inflammatory status can be crucial for improving systemic 
insulin resistance. 
 
1.2.2 Macrophage 
Macrophage activation plays a crucial role in regulating adipose tissue inflammation and 
metabolic disorders [11-15]. There are diverse macrophage phenotypes identified, but it 
is not well known about how one type of macrophages differs from the others, and 
whether different types of macrophages overlap in functional properties. Additionally, 
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the classification of macrophage phenotypes is still under development. The two most 
common macrophage phenotypes are the classically-activated M1 macrophages and the 
alternatively-activated M2 macrophages. Macrophage M1 activation (proinflammatory) 
is driven by Th1 cytokines, such as interferon gamma (IFNᵞ) and TNFα, or by 
lipopolysaccharides (LPS) recognition [16-18]. M1 cells secrete proinflammatory 
cytokines, such as TNFα, IL-6, IL-1β [16-18]. M1 macrophages exhibit microbicidal 
properties and serve a defensive role in acute inflammatory response. However, 
prolonged or chronic inflammation is pathogenic and should be counteracted by 
protective mechanisms operated by anti-inflammatory M2 macrophages. Macrophage 
M2 activation (anti-inflammatory) is typically driven by Th2 cytokines, such as IL-4 and 
IL-13. Characterized by high endocytic clearance and anti-inflammatory capacities, M2 
macrophages can promote repair of tissue damage and protect surrounding tissues from a 
detrimental immune response [19] (Fig. 2).  
In classically-activated macrophages, nuclear factor kappa B (NF-κB) and/or c-
Jun N-terminal kinase 1 (JNK1) signaling mediates the expression of proinflammatory 
cytokines. Under the condition of overnutrition, increased macrophage proinflammatory 
activation is a causal factor of insulin resistance [20]. In contrast, PPARγ is the known 
intracellular determinant that stimulates macrophage M2 activation [3, 4, 21, 22]. 
Increased M2 activation is associated with improvement of systemic insulin sensitivity 
and appears to protect against the development of obesity-associated metabolic diseases 
[3, 4].   
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Figure 2. Macrophage proinflammatory (M1) activation and anti-inflammatory 
(M2) activation. 
 
 
 
 
1.2.3 Circadian clocks 
Many physiological processes display a 24-h rhythm, including fasting-feeding behavior, 
sleep-wake cycle, hormones level oscillation, and lipid/carbohydrate metabolism. [23] 
This 24-h rhythm is driven by an endogenous and entrainable circadian clock [23], 
which can also be adjusted to the local environment by external cues such as light-dark 
cycle and temperature [24]. When circadian rhythms are desynchronized by shift work, 
jet lag, and/or sleep disruption, human normal body weight regulation and glucose/lipid 
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homeostasis is profoundly affected [25-27]. Circadian dysregulation also is widely 
observed in obesity and metabolic syndrome. It has been demonstrated that HFD 
disrupts behavioral and molecular circadian rhythms in mice [28]. As many hormones 
involved in glucose homeostasis and insulin secretion are regulated by the circadian 
system [29, 30], the disruption of circadian rhythms leads to insulin resistance and 
obesity [31]. 
The core loop of circadian clock is responsible for rhythmic biological processes, 
existing in both brain and peripheral metabolic tissues, such as adipose, liver, and 
macrophage (Fig. 3). Within the core loop of the circadian clock, CLOCK-BMAL1 
induces transcription of clock genes Per1/Per2/Per3 and Cry1/Cry2, as well as clock-
controlled genes. The protein products PERs and CRYs can form a complex in the 
cytoplasm, and it either translocates to nucleus to inhibit CLOCK-BMAL1 or is 
degraded after phosphorylation. This cycle typically takes 24 h. Thus, the circadian 
clock coordinates metabolic and immune processes in peripheral tissues in a day-night 
cycle through regulating transcription of genes involved, such as the gene of insulin in 
pancreas, leptin in adipose and cytokines in immune cells [23].  
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Figure 3. The core loop of circadian clocks is responsible for rhythmic biological 
processes. CCGs, clock-controlled genes. 
 
 
 
 
1.2.4 PFKFB3/inducible 6-phosphofructo-2-kinase (iPFK2) 
PFKFB3/iPFK2 is the key regulatory enzyme in the glycolytic pathway (Fig. 4). In 
glucose metabolism, fructose-2, 6-bisphosphate (F-2, 6-P2) is a powerful activator of 6-
phosphofructo-1-kinase (6PFK1), which is the rate-limiting enzyme of glycolysis. 
Meanwhile, F-2, 6-P2 is also a powerful inhibitor of fructose-1, 6-bisphosphatase, which  
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Figure 4. PRKFB3 in glycolysis pathway. 
 
 
 
 
is the key enzyme of gluconeogenesis [32, 33]. The synthesis and degradation of F-2, 6-
P2  is catalyzed by 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase (PFK- 
2/FBPase), which is a homodimeric bi-functional enzyme encoded by PFKFB gene, 
which include PFKFB1-4 encoding tissue-specific pfkfb isoenzymes [32-34]. The 
PFKFB3 gene encodes for the isoenzyme iPFK2 [35, 36] and is expressed in rapidly 
  9 
proliferating cells, such as tumor cells, epithelial cells, and activated immune cells [35, 
36]. Additionally, tissue distribution analysis has shown that PFKFB3 is highly 
expressed in adipose tissue and is expressed at very low levels in liver and muscle [10]. 
In macrophages, PFKFB3 is the predominant PFKFB gene and the expression is 
stimulated by LPS [37] and hypoxia [32], suggesting a role for PFKFB3 in macrophage 
inflammatory responses. Homozygous disruption of PFKFB3/iPFK2 results in lethal 
embryo, which indicates this gene is critical for fetus survivial. However, there are few 
published data that address the role of PFKFB3 in macrophage inflammatory status 
regulation and its relation to insulin resistance during obesity.   
Previous studies of my colleagues in the lab have shown that HFD-fed global 
PFKFB3-disrupted mice gained less body weight and exhibited less adiposity when 
compared to WT mice after HFD feeding [10]. These HFD-fed PFKFB3-disrupted mice, 
however, displayed increased severity of systemic insulin resistance and adipose tissue 
dysfunction. This was evidenced by abnormal adipose tissue lipolysis, adipokine 
expression, proinflammatory responses, and impaired insulin signaling [10, 14]. 
Interestingly, increased adipose tissue inflammatory response and less macrophage 
infiltration in adipose tissue were observed concurrently in HFD-fed PFKFB3-disrupted 
mice, when compared with HFD-fed WT mice. This indicated that adipose tissue 
inflammatory response, rather than the number of infiltrated macrophages in adipose 
tissue, is more crucial in determining adipose tissue inflammation, insulin signaling and 
systemic insulin resistance.  
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Studies from others also suggested that macrophage inflammatory activation 
status is more important than the total number in adipose tissue for the inflammatory 
cytokines production. For example, mice lacking PPARγ in macrophages exhibited 
lower levels of macrophage infiltration in adipose tissue but displayed increased mRNA 
levels of IL-6, when compared to WT control [3, 38]. Rosiglitazone, as a PPARγ 
agonist, increased the total number of macrophages infiltrated in adipose tissue but 
decreased the expression of proinflammatory cytokines such as IL-18 [3, 38].  
Additionally, researchers have demonstrated that iPFK2 is involved in the anti-
diabetic effect of PPARγ activation in mice [15]. Considering the effect of PPARγ on 
macrophage activation, whether PFKFB3 is also involved in the process of macrophage 
activation in the context of systemic insulin resistance would be an interesting topic to 
investigate. 
Therefore, my hypothesis is 1) circadian clock dysregulation enhances 
macrophage proinflammatory activation in diet-induced obesity, resulting in local and 
systemic insulin resistance; 2) PFKFB3 disruption enhances macrophage 
proinflammatory activation in diet-induce obesity, resulting in local and systemic insulin 
resistance. 
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2. CIRCADIAN CONTROL OF MACROPHAGE ACTIVATION*
2.1 Introduction 
Obesity is highly associated with systemic insulin resistance and the consequential 
development of a wide variety of metabolic diseases including type 2 diabetes [39], fatty 
liver disease [40], and cardiovascular disease [41]. Over the past decade, adipose tissue 
inflammation has been increasingly regarded as a causal factor of obesity-associated 
insulin resistance [10, 12, 42-44]. As demonstrated in mice fed a high fat diet (HFD), 
adipose tissue develops low grade inflammation that is characterized by increased 
infiltration of immune cells and production of proinflammatory cytokines [12, 42]. The 
diet-induced proinflammatory signaling coupled with increased production of pro-
hyperglycemic factors (e.g. free fatty acids and resistin) and decreased production of 
anti-hyperglycemic factors (e.g. adiponectin) that reflect inflammation-associated 
adipose tissue dysfunction [45-48] collectively impair insulin signaling in insulin-
sensitive tissues including the liver and skeletal muscle, leading to systemic insulin 
resistance [49-54]. In contrast, treatment with thiazolidinediones or supplementation 
with fish oils ameliorates adipose tissue inflammation, which in turn contributes to the  
* Reprinted from Xu H, Li H, Woo SL, Kim SM, Shende VR, Neuendorff N, Guo X, 
Guo T, Qi T, Pei Y, Zhao Y, Hu X, Zhao J, Chen L, Chen L, Ji JY, Alaniz RC, Earnest 
DJ, and Wu C. Myeloid cell-specific disruption of Period1 and Period2 exacerbates 
diet-induced inflammation and insulin resistance. This research was originally 
published in J Biol Chem, 2014. 289:16374-16388. Copyright 2014 by the American 
Society for Biochemistry and Molecular Biology.
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reversal of diet-induced adipose tissue dysfunction and systemic insulin resistance [55-
57]. As such, obesity-associated inflammation is key to the regulation of systemic 
insulin sensitivity. 
In relation to the link between inflammation and metabolic dysregulation in 
obesity, there is increasing evidence that dysregulated macrophage functional plasticity 
and versatility (polarization) is a key component of the mechanism by which 
inflammation in adipose and liver tissues mediates the development of obesity-
associated insulin resistance and metabolic diseases. For example, in diet-induced 
obesity, adipose tissue macrophage infiltration is increased, and polarization is shifted 
toward the proinflammatory M1 activation, resulting in increased production of 
proinflammatory cytokines and potentiation of adipose tissue inflammation that 
contribute to impaired systemic insulin sensitivity [58]. Within macrophages, 
peroxisome proliferator-activated receptor γ and δ (PPAR γ / δ) are key transcription 
factors that stimulate macrophage alternative M2 (anti-inflammatory) activation [22, 59, 
60]. Importantly, myeloid cell-specific disruption of PPARγ and/or PPARδ increases 
proinflammatory activation of adipose tissue macrophages and exacerbates obesity-
associated insulin resistance [43, 59]. In contrast, the effect of PPARγ activation on 
reversing HFD-induced insulin resistance is mediated at least in part by stimulation of 
alternative activation of macrophages in adipose tissue [56]. Macrophage polarization is 
also regulated by Toll-like receptor 4 (TLR4) and/or c-Jun N-terminal kinase (JNK) such 
that their myeloid cell-specific disruption protects mice from diet-induced adipose tissue 
inflammation and systemic insulin resistance [61-63]. As such, these findings 
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demonstrate how the inflammatory status of macrophages governs the outcome of 
adipose tissue inflammation and systemic insulin sensitivity. 
Circadian clocks in peripheral tissues and cells drive daily rhythms and 
coordinate many physiological processes including inflammation and metabolism. 
Recent observations suggest that circadian clock dysregulation plays a key role in the 
development of metabolic diseases including obesity and diabetes. Studies using mice 
with genetic mutation or deletion of core clock genes correspondingly indicate that 
global and adipocyte specific disruption of circadian clock function produces obesity or 
significant alterations in metabolism [64-66]. However, the specific mechanism 
underlying the link between circadian clock- and metabolic-dysregulated phenotypes is 
unknown. As key components of inflammation in obesity, macrophages contain cell-
autonomous circadian clocks that have been shown to gate macrophage inflammatory 
responses including rhythms in lipopolysaccharide (LPS)-induced cytokine secretion 
[67, 68]. Because HFD induces adipose tissue circadian clock dysregulation in 
conjunction with adipose tissue macrophage proinflammatory activation [28] and 
environment-mediated circadian disruption amplifies macrophage proinflammatory 
responses [69], our hypothesis is that overnutrition causes circadian clock dysregulation, 
which in turn induces macrophage proinflammatory activation in adipose tissue so as to 
exacerbate inflammation and fat deposition, thus leading to systemic insulin resistance. 
To test this hypothesis, we conducted a series of experiments to determine whether 1) 
HFD induces circadian clock dysregulation along with proinflammatory activation in 
indigenous and adipose tissue macrophages, 2) genetic disruption of the clock 
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mechanism using mice with targeted mutations of the clock genes Period1 (Per1) and 
Per2 (Per1ldc/Per2ldc) alters macrophage proinflammatory status, 3) PPARγ plays a role 
in the proinflammatory activation of Per1/2-disrupted macrophages, and 4) adoptive 
transfer or co-culture of Per1/2-disrupted macrophages potentiates inflammatory 
responses and pathophysiology of adipose tissue in diet-induced obesity or adipocytes in 
vitro. 
 
2.2 Materials and Methods 
2.2.1 Animal experiments 
Animals used in this study were derived from wild-type (WT) C57BL/6J mice and 129J 
mice obtained from The Jackson Laboratory (Bar Harbor, ME) and from breeding pairs 
of homozygous mPer2Luc knockin mice (C57BL/6J background; generously provided 
by Dr. Joseph Takahashi, UT Southwestern Medical School, Dallas, TX) and 
homozygous mutant mice with targeted disruption of the clock genes, Per1 and Per2 
(Per1ldc/Per2ldc; generously provided by Dr. David Weaver, University of 
Massachusetts Medical School, Worcester, MA). In homozygous mPer2Luc mice, a 
luciferase (Luc) gene was fused in-frame to the C terminus of the endogenous mPER2 
coding sequence so as to enable continuous recording of Per2 oscillations via luciferase 
bioluminescence [70]. Establishment, genotyping, and phenotype of Per1ldc/Per2ldc 
mutant mice (129J background) have been described previously [71]. Per1ldc/Per2ldc 
mice are distinguished by a loss of circadian rhythmicity as well as altered expression 
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and circadian regulation of other clock genes [71]. In different peripheral tissues, 
Per1ldc/Per2ldc mutant mice consistently showed increased BMAL1 (600%) and 
increased CLOCK ( 65%) protein levels relative to WT controls.5 All mice were 
maintained on a 12:12-h light-dark cycle (lights on at 06:00). At 5–6 wk of age, male 
wild-type C57BL/6J mice were fed an HFD (60% fat calories, 20% protein calories, and 
20% carbohydrate calories) or a low fat diet (LFD, 10% fat calories, 20% protein 
calories, and 70% carbohydrate calories) for 12 wk as previously described [10, 44] 
(nutrient composition listed in Table. 1). After the feeding regimen, mice were fasted for 
4 h before sacrifice for collection of blood and tissue samples [72, 73]. Epididymal, 
mesenteric, and perinephric fat depots were dissected and weighed as abdominal fat 
mass [73]. After weighing, adipose tissue and liver samples were either fixed and 
embedded for histological and immunohisto-chemical analyses or frozen in liquid 
nitrogen and stored at 80 °C for further analyses. Some mice were fasted similarly and 
used for insulin and glucose tolerance tests and/or and insulin signaling analyses as 
described below. To examine the dietary effect on in vivo circadian clock rhythmic in 
relation to obesity-associated metabolic phenotypes, mPer2Luc mice were subjected to 
HFD feeding. Briefly, female homozygous mPer2Luc mice at 5–6 wk of age were fed an 
HFD for 12 wk. Ageand gender-matched mPer2Luc mice were fed an LFD and used as 
controls. After the feeding regimen mPer2Luc mice were subjected to the same assays 
used for C57BL/6J mice. Additionally, both HFD-fed and LFD-fed mPer2Luc mice 
were subjected to examination of wheel-running locomotor activity rhythms as  
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Table 1. Macro- and micronutrient composition of low-fat and high-fat diets. 
 LFD 
3.85 kcal/gm 
HFD 
5.24 kcal/gm 
Macronutrients gm% kcal% gm% kcal% 
Protein 19.2 20 26 20 
Carbohydrate 67.3 70 26 20 
Fat 4.3 10 35 60 
Total  100  100 
Ingredients gm kcal gm Kcal 
Casein, 80 Mesh 200 800 200 800 
L-Cystine 3 12 3 12 
Corn Starch 315 1260 0 0 
Maltodextrin 10 3 140 125 500 
Sucrose 350 1400 68.8 275 
Cellulose, BW200 50 0 50 0 
Soybean Oil 25 225 25 225 
Lard 20 180 245 2205 
Mineral Mix S10026 10 0 10 0 
DiCalcium Phosphate 13 0 13 0 
Calcium Carbonate 5.5 0 5.5 0 
Potassium Citrate, 1 H2O 16.5 0 16.5 0 
Vitamin Mix V10001 10 40 10 40 
Choline Bitartrate 2 0 2 0 
FD&C Yellow Dye #5 0.05 0 0 0 
FD&C Blue Dye #1 0 0 0.05 0 
Total 1055.05 4057 773.85 4057 
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previously described [74]. Some age-matched female mPer2Luc mice were fed ad 
libitum and used for isolation of bone marrow cells.  
To address a role for circadian clock rhythmic dysregulation in altering 
macrophage activation in relation to metabolic homeostasis, Per1ldc/Per2ldc mice were 
used for the present study. Accordingly, Per1ldc/Per2ldc mice (129J background) and 
wild-type 129J mice were maintained on a 12:12-h light-dark cycle (lights on at 06:00) 
and fed ad libitum. At 5– 6 wk of age, male Per1ldc/Per2ldc mice and wild-type 129J 
mice were anesthetized by ketamine (100 mg/kg)/xylazine (10 mg/kg of body weight). 
Immediately after euthanasia, Per1ldc/Per2ldc mice and wild-type 129J mice were 
subjected to isolation of bone marrow cells as previously described [60, 62]. The isolated 
bone marrow cells were used for in vitro analyses and served as donor cells for bone 
marrow transplantation (BMT). Briefly, male wild-type C57BL/6J recipient mice at 5–6 
wk of age were lethally irradiated and subjected to BMT to generate chimeric mice using 
the established method [60, 61]. Wild-type C57BL/6J mice that were transplanted with 
donor cells from Per1ldc/Per2ldc mice were referred to as BMT-Per1ldc/Per2ldc mice. 
Wild-type C57BL/6J mice that were transplanted with donor cells from wild-type 129J 
mice were referred to as BMT-WT mice. After recovery for 4 wk, all chimeric mice 
were subjected for HFD feeding for 12 wk followed by metabolic assays. All study 
protocols were reviewed and approved by the Institutional Animal Care and Use 
Committee of Texas A&M University.  
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2.2.2 Macrophage differentiation and characterization 
Bone marrow cells were isolated from the tibias and femurs of LFD- and/or HFD-fed 
mPer2Luc mice as previously described [59]. After differentiation with Iscove’s 
modified Dulbecco’s medium containing 10% fetal bovine serum and 15% L929 culture 
supernatant for 8 d, bone marrow-derived macrophages (BMDMs) were subjected to 
inflammatory assays and circadian rhythm analyses using a lumicycle. Similarly, bone 
marrow cells were isolated from chow diet-fed Per1ldc/Per2ldc mice and 129J WT 
control mice and differentiated into BMDM for FACS analyses using flow cytometry 
with fluorescence-conjugated antibodies against F4/80 and CD11b as well as CD11c and 
CD206. For PPAR rescue experiment, Per1ldc/Per2ldc BMDM were treated with a 
PPAR 2-expressing lentiviral vector or a control vector for 24 h according to procedures 
provided with commercial kits (GenTarget Inc, San Diego, CA). WT BMDM (129J 
background) were treated similarly with a control vector and served as the control (Ctrl). 
Untreated WT BMDM were also included as controls. After incubation for an additional 
24 h, the treated BMDM were subjected to inflammatory analyses. To examine 
macrophage proinflammatory activation, BMDM were treated with LPS (100 ng/ml) or 
PBS for 30 min before cell harvest to examine the inflammatory signaling using Western 
blot analyses. Some cells were treated with or without LPS at the same dose for 6 h 
before harvest of RNA samples. Some cells were subjected to FACS analyses as 
described below.  
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2.2.3 Confirmation of Per1/2 disruption 
Genomic DNA was prepared from the tails of Per1ldc/Per2ldc mice and 129J wild-type 
mice as well as bone marrow cells, bone marrow-derived macrophages, and adipose 
tissue and liver samples of chimeric mice and subjected to PCR genotyping using 
previously described methods [75].  
 
2.2.4 Insulin and glucose tolerance tests 
Mice were fasted for 4 h and intraperitoneally injected with insulin (1 unit/kg of body 
weight) or D-glucose (2 g/kg of body weight). For insulin tolerance tests, blood samples 
(5 ul) were collected from the tail vein before and at 15, 30, 45, and 60 min after the 
bolus insulin injection. Similarly, for glucose tolerance tests blood samples were 
collected from the tail vein before and at 30, 60, 90, and 120 min after the glucose bolus 
injection [10, 44].  
 
2.2.5 Measurement of metabolic parameters 
The levels of plasma glucose, triglycerides, and free fatty acids were measured using 
metabolic assay kits (Sigma and BioVision, Mountain View, CA). The levels of plasma 
insulin were measured using ELISA kits (Crystal Chem Inc., Downers Grove, IL).  
 
2.2.6 Isolation of stromal vascular cells from adipose tissue 
Adipose tissue stromal vascular cells (SVCs) were isolated using the collagenase 
digestion method as previously described [10, 56]. After digestion and centrifugation, 
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the pelleted cells were collected as SVC. Adipose tissue SVC from mPer2Luc mice were 
subjected to bioluminescence analysis as previously described [75]. SVC from HFD-fed 
BMT-Per1ldc/Per2ldc and BMT-WT mice were subjected to FACS analyses and other 
assays.  
 
2.2.7 Circadian properties of mPer2Luc SVC and BMDM cells 
SVC and BMDM prepared from LFD- and/or HFD-fed mPer2Luc mice were suspended 
in supplemented Dulbecco’s modified Eagle’s medium (DMEM) (for SVC) or Iscove’s 
modified Dul becco’s medium (for BMDM) and then plated on 35-mm culture dishes 
(Corning). For both cell types, the medium was changed 24 h after plating so as to 
reduce the FBS concentration to 5%, and about 12 h later cultures were exposed to 
medium containing 50% adult horse serum for 2 h. Thereafter, serum-shocked SVC and 
BMDM were maintained in serum- free recording medium containing 0.1 mM beetle 
luciferin (Promega), 25 units/ml penicillin, and 25 g/ml streptomycin for 
bioluminescence analysis as described previously [74]. Individual cultures were sealed 
airtight with sterile glass coverslips (VWR) and sterile silicon grease (Dow Corning). 
The temporal patterns of mPER2::LUC bioluminescence were analyzed using an 
automated 32-channel luminometer (LumiCycle; Actimetrics, Wilmette, IL) that was 
maintained within a standard cell culture incubator at 35 °C. Bioluminescence from 
individual cultures was continuously recorded with a photomultiplier tube (PMT) for 70 
s at intervals of 10 min. Because of the transient induction of bioluminescence after the 
medium change at the initiation of this analysis, the first cycle was excluded from data 
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analysis. Bioluminescence data were analyzed using the Lumicycle Analysis program 
(Actimetrics). For each raw data set, baseline drift was removed by fitting a polynomial 
curve with an order equal to one less than the number of recorded cycles. Rhythm 
parameters were determined from baseline-subtracted data using Levenberg-Marquardt 
algorithm (damped Sine) fit.  
 
2.2.8 Flow cytometry analysis 
Tibias/femurs were obtained from LFD- or HFD-fed mPer2Luc (n 3) and from chow 
diet- fed Per1ldc/Per2ldc mice and 129J wild-type mice (n 3) and pooled to obtain 
sufficient BMDM. Epididymal fat pads were obtained from HFD-fed BMT-
Per1ldc/Per2ldc mice and BMT- WT mice to prepare SVC samples (n 4–6). BMDM 
and adipose tissue SVC were stained with fluorescence-tagged antibodies (anti-F4/80 
and anti-CD11b for macrophages and anti- CD11c and anti-CD206 for macrophage 
activation as previously described [76]) and subjected to FACS analyses using BD 
FACS Aria II flow cytometer (BD Biosciences) that is operated by Texas A&M Health 
Science Center College of Medicine Cell Analysis Facility. Briefly, the harvested cells 
were analyzed based on FSC-A and SSC-A. Live cells were then examined for F4/80 
(FITC) and CD11b allophycocyanin (APC) expression. Mature macrophages (F4/80 
CD11b cells) were then gated for CD11c (phycoerythrin (PE)/Cy7) and CD206 (PE) 
expression (macrophage polarization). Mature macrophages that were positive for 
CD11c but negative for CD206 were considered as M1 macrophages (F4/80 CD11b 
CD11c CD206 cells).  
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2.2.9 Co-culture of macrophages and adipocytes 
BMDM were prepared from Per1ldc/Per2ldc and 129J wild-type control mice. 
Adipocytes were differentiated from 3T3-L1 cells in DMEM supplemented with 10 g/ml 
insulin, 1 M dexamethasone, and 0.5 mM 3-isobutyl-1-methyl-xanthine for 48 h 
followed by incubation for an additional 6 – 8 d in growth medium supplemented with 
10 g/ml insulin [10, 77]. After differentiation, adipocytes were co-cultured with BMDM 
at a ratio of 10:1 based on the published method [60]. To examine changes in 
inflammatory signaling, the cells were treated with or without LPS (10 ng/ml) for 30 min 
before cell harvest. Some cells were treated with or without insulin (100 nM) for 30 min 
before harvest for determination of changes in insulin signaling. Cell lysates were 
prepared and used to examine inflammatory and insulin signaling using Western blot 
analyses. Additionally, some co-culture cells were treated with or without LPS (10 
ng/ml) for 6 h and subjected to preparation of RNA samples to quantify gene expression 
using real-time reverse transcription PCR.  
 
2.2.10 Western blots 
Lysates were prepared from frozen tissue samples and cultured cells using the lysis 
buffer containing 50 mm HEPES (pH 7.4), 1% Triton X-100, 50 mm sodium 
pyrophosphate, 0.1 m sodium fluoride, 10 mm EDTA, 10 mm sodium orthovanadate, 10 
g/ml aprotinin, 10 g/ml leupeptin, 2 mm benzamidine, and 2 mm phenylmethylsulfonyl 
fluoride. The levels of JNK1/2, phospho-JNK1/2, nuclear factor B (NF- κB) p65, 
phospho-p65 (Ser-536), Akt1/2, phospho-Akt (Ser-473), and PPAR in cell lysates (15 or 
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50 g/lane) were analyzed using 8% Tris-glycine gels and rabbit anti-serum as a primary 
antibody at a 1:1000 dilution. The blot was followed by a 1:10,000 dilution of goat anti-
rabbit horseradish peroxidase- conjugated secondary antibody kit (ImmobilonTM 
Western; EMD Millipore, Billerica, MA) as previously described [73]. GAPDH or -actin 
was used as a loading control. The maximum intensity of each band was quantified using 
ImageJ software. Ratios of PJNK1/JNK1 and phospho-p65/p65 as well as phospho-
Akt/Akt were normalized to GAPDH or -actin and adjusted relative to the average of 
control (PBS)-treated LFD, wild type, Per1ldc/Per2ldc, BMT-WT, or Adi/wild type, 
which was arbitrarily set as 1 (arbitrary units).  
 
2.2.11 RNA isolation, reverse transcription, and real-time PCR 
The total RNA was isolated from frozen tissue samples and cultured/isolated cells. 
Reverse transcription was performed using the GoScriptTM Reverse Transcription 
System (Promega), and real-time PCR analysis was performed using SYBR Green (ABI 
Prism 7200 Sequence Detection System; Applied Biosystems) [78, 79]. The mRNA 
levels were analyzed for interleukin-1 (IL-1), IL-6, tumor necrosis factor (TNF), IL-10, 
arginase1, monocyte chemoattractant protein 1 (MCP1), TLR4, adiponectin, hormone-
sensitive lipase, resistin, sterol regulatory element-binding protein 1c (SREBP1c), 
acetyl-CoA carboxylase 1, fatty acid synthase (FAS), glucokinase, and glucose-6-
phosphatase in tissue and/or cell samples. A total of 0.1 g of RNA was used for the 
determination. Results were normalized to 18 S ribosomal RNA or -actin mRNA and 
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plotted as relative expression to the average of control (PBS)-treated LFD, wild type, 
Per1ldc/Per2ldc, BMT-WT, or Adi/wild-type, which was arbitrarily set as 1. 
 
2.2.12 Statistical methods 
Numeric data are presented as the means S.E. Statistical significance was assessed by 
unpaired, two-tailed analysis of variance or Student’s t tests. Differences were 
considered significant at the two-tailed p 0.05.  
 
2.3 Results 
2.3.1 HFD feeding induces adiposity, adipose tissue inflammation, systemic insulin 
resistance, and circadian clock dysregulation 
Consistent with established observations [10, 12, 42], HFD-fed C57BL/6J mice 
displayed increased adiposity, adipose tissue inflammation, and systemic insulin 
resistance (Fig. 5).  
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Figure 5. HFD feeding induces adiposity, adipose tissue inflammation, and systemic 
insulin resistance.  
At 5 – 6 wk of age, C57BL/6J male mice were fed a high-fat diet (HFD) or low-fat diet 
(LFD) for 12 wk (n = 5 – 10). (A) Body weight was recorded weekly during the feeding 
regimen. (B) Adipose mass. Abdominal fat mass (visceral fat) was the sum of 
epididymal, mesenteric and perinephric fat mass. (C) Adipose tissue inflammatory 
signaling. The levels of total and phosphorylated NF-κB p65 were examined using 
Western blot analyses and quantified using densitometry. (D) Insulin tolerance tests. (E) 
Glucose tolerance tests. Data are means ± SE in line and bar graphs. *, P < 0.05; **, P < 
0.01; and ***, P<0.001 HFD vs. LFD (C) for the same time point (A, D and E) or the 
same fat pad (B). For B and C, mice were fasted for 4 hour starting at the same time of 
the day prior to tissue collection or physiological assays. For D and E, mice were fasted 
for 4 hour starting at the same time of the day prior to be given a peritoneal injection of 
insulin (1 U/kg) (D) or glucose (2 g/kg) (E). AU, arbitrary units. 
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To address a possible link between metabolic phenotype and alterations in 
circadian clock functions, homozygous mPer2Luc knockin mice (C57BL/6J background) 
(Fig. 6) were subjected to an identical feeding regimen. After HFD feeding for 12 wk, 
mPer2Luc mice exhibited a marked increase in body weight and abdominal fat mass 
compared with LFD-fed mice (Fig. 7).  
 
 
 
 
 
Figure 6. Homozygous mPer2Luc knockin mice.  
The expressed PERIOD2::LUCIFERASE fusion protein is used as a real-time reporter of 
circadian dynamics in mice. 
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Figure 7. HFD feeding to mPer2Luc mice induces adiposity.  
At 5 – 6 wk of age, mPer2Luc mice were fed a high-fat diet (HFD) or low-fat diet (LFD) 
for 12 wk (n = 5 – 10). (A) Body weight was recorded weekly during the feeding 
regimen. (B) Adipose mass. Abdominal fat mass was calculated from the sum of gonadal 
and perinephric fat content. Data are means ± SE in line and bar graphs. *, P < 0.05; **, 
P < 0.01 HFD vs. LFD for the same time point (A) or the same fat pad (B). For B, mice 
were fasted for 4 hour starting at the same time of the day prior to tissue collection or 
physiological assays. 
 
 
 
 
 
 
 
 
Consistent with HFD-fed C57BL/6J mice, HFD-fed mPer2Luc mice exhibited a 
significant increase in the severity of insulin resistance and glucose intolerance indicated 
by insulin and glucose tolerance tests, respectively (Fig. 8). Additionally, HFD-fed 
mPer2Luc mice displayed a significant increase in the period of the circadian rhythm of 
wheel-running behavior (Fig. 9). 
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Figure 8. HFD feeding to mPer2Luc mice induces systemic insulin resistance.  
At 5 – 6 wk of age, mPer2Luc mice were fed a high-fat diet (HFD) or low-fat diet (LFD) 
for 12 wk (n = 5 – 10). (A) Insulin tolerance tests. (B) Glucose tolerance tests. Data are 
means ± SE in line and bar graphs. *, P < 0.05; **, P < 0.01 HFD vs. LFD for the same 
time point. Mice were fasted for 4 hour starting at the same time of the day prior to be 
given a peritoneal injection of insulin (1 U/kg) (A) or glucose (2 g/kg) (B). 
 
 
 
 
Figure 9. HFD feeding to mPer2Luc mice induces circadian clock dysregulation. 
At 5 – 6 wk of age, mPer2Luc mice were fed a high-fat diet (HFD) or low-fat diet (LFD) 
for 12 wk (n = 5 – 10). Representative circadian rhythms of wheel-running activity in 
LFD- and/or HFD-fed mice during exposure to constant darkness. Bar graph depicts 
differences in the free-running period of the activity rhythm between treatment groups. 
Data are means ± SE in line and bar graphs. ***, P < 0.001 HFD vs. LFD (right panel). 
The rhythm data were generated by the collaborator Dr. Earnest’s lab. 
 
  29 
2.3.2 HFD feeding lengthens the period of clock gene oscillations in adipose tissue 
SVC and BMDM and increases macrophage proinflammatory activation 
Given the role of macrophages in inflammation [10, 12], we analyzed circadian 
oscillations of the clock gene Per2 in adipose tissue SVC, the immune cell-containing 
fraction of collagenase-digested visceral fat that has been widely used to examine the 
inflammatory status of adipose tissue macrophages [12, 59], and BMDM derived from 
mPer2Luc mice (Fig. 10). 
 
 
 
 
 
Figure 10. Preparation of BMDM. 
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SVC cultures from LFD-fed mice exhibited robust mPER2::LUC rhythms with a 
circadian period of 25.06 ± 0.4h (Fig. 11A). However, SVC cultures from HFD-fed mice 
were characterized by mPER2::LUC rhythms in which the period was significantly 
increased by ~9h (Fig. 11A). Similarly, the period of BMDM rhythms in mPER2::LUC 
bioluminescence was significantly increased in cultures from HFD-fed mPer2Luc mice 
relative to those from LFD-fed mice (Fig. 11B). BMDM cultures from HFD-fed 
mPer2Luc mice were also distinguished by robust decreases in the amplitude of the 
mPER2::LUC rhythm (Fig. 11B).  
When the inflammatory status was analyzed under basal conditions (PBS-
treated), the phosphorylation of JNK1 (p46, the key JNK isoform that mediates 
proinflammatory signaling) and NF-kB p65 (Ser-536) in BMDM from HFD-fed 
mPer2Luc mice did not significantly differ from that in BMDM from LFD-fed mice. 
However, upon LPS treatment, the phosphorylation of JNK1 and NK-kB p65 (Ser-536) 
in BMDM from HFD-fed mPer2Luc mice was significantly increased by 2.1- and 1.6 
fold, respectively, compared with that in BMDM from LFD-fed mice (Fig. 12A). 
Moreover, under both basal and LPS-treated conditions, IL-1b, IL-6, and TNFa mRNA 
levels in BMDM from HFD-fed mPer2Luc mice were increased significantly relative to 
their respective levels in BMDM from LFD-fed mice (Fig. 12B).  
Thus, overnutrition increases macrophage proinflammatory activation in concert 
with its effects on altering the timekeeping function of the macrophage circadian 
clockworks. 
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Figure 11. Overnutrition lengthens the period of clock gene oscillations in adipose 
tissue SVC and in BMDM.  
At 5 – 6 wk of age, mPer2Luc mice were fed an HFD or LFD for 12 wk (n = 5 – 6). 
Representative recordings of ensemble PER2::LUC bioluminescence (expressed as 
detrended baseline subtracted counts per second) from cultured adipose tissue stromal 
vascular cells (SVC) (A) or bone marrow-derived macrophages (BMDM) (B). Bar 
graphs depict group differences in PER2::LUC rhythm period between treatment groups. 
For bar graphs, data are means ± SE. *, P < 0.05 HFD vs. LFD. The bioluminescence 
data were generated by the collaborator Dr. Earnest’s lab. 
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Figure 12. Overnutrition enhances macrophage proinflammatory responses. 
At 5 – 6 wk of age, mPer2Luc mice were fed an HFD or LFD for 12 wk (n = 5 – 6). (A) 
Macrophage inflammatory signaling. Prior to harvest, BMDM were treated with LPS 
(100 ng/ml) or PBS for 30 min. The levels of JNK1 (p46), phospho-JNK1, NF-κB p65, 
and phospho-p65 (Ser-536) were examined using Western blot analyses and quantified 
using densitometry. (B) Macrophage IL-1β, IL-6, and TNF-α mRNA expression. Prior to 
harvest, BMDM were treated with LPS (100 ng/ml) or PBS for 6 hr. IL-1β and TNF-α 
mRNA levels were quantified using real-time PCR and plotted as relative expression. 
For bar graphs, data are means ± SE. *, P < 0.05 and **, P < 0.01 HFD vs. LFD under 
the same condition (PBS or LPS). AU, arbitrary units. 
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To address a direct role for circadian clock disruption in altering macrophage 
inflammatory status, BMDM obtained from mutant mice with targeted disruption of the 
clock genes Per1 and Per2 (Per1ldc/Per2ldc, 129J background), which are characterized by 
a loss of circadian rhythmicity [71], and BMDM from WT 129J mice were subjected to 
FACS analyses (Fig. 13).  
Figure 13. Flow chart of the FACS analysis for macrophage M1/M2 activation. 
All Cells Harvested
Live  Cells
Mature  Macrophages
M1 Macrophages M2 Macrophages
Based on FSC-A, SSC-A
population distribution
FITC-F4/80     positive
APC-CD11b    positive
PE/Cy7-CD11c  positive
PE-CD206     negative
PE/Cy7-CD11c  negative
PE-CD206          positive
2.3.3 Circadian clock disruption increases macrophage proinflammatory activation 
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Among the analyzed cells, >95% of a total of 20,000-30,000 cells were mature 
macrophages (F4/80+CD11b+ cells) (Fig. 14A, quantitative data not included). Mature 
macrophages were then examined for activation status based on CD11c and CD206 
expression (Fig. 14B top panel). Compared with controls, BMDM from Per1ldc/Per2ldc 
mutant mice displayed a significantly higher percentage of proinflammatory (M1) 
macrophages (F4/80+CD11b+CD11c+CD206- cells ) and no difference in percentage of 
anti-inflammatory (M2) macrophages (F4/80+CD11b+CD11c-CD206+ cells)(Fig. 14B 
bottom panel).  
When inflammatory signaling was examined under basal conditions (PBS-
treated), BMDM levels of JNK1 phosphorylation remained low with no genotype-based 
differences (Fig. 15A. However, in response to LPS, the phosphorylation of JNK1 in 
BMDM from Per1ldc/Per2ldc mice was significantly increased compared with that in 
BMDM from WT mice. Additionally, under both basal and LPS-treated conditions, NF-
kB p65 (Ser-536) phosphorylation in BMDM from Per1ldc/Per2ldc mice was 
significantly higher than that in BMDM from WT mice. Among proinflammatory 
cytokines that were examined, IL-1b and TNFa mRNA expression in BMDM under both 
basal and LPS-treated conditions differed in accord with genotype (Fig. 15B). Compared 
with controls, BMDM from Per1ldc/Per2ldc mice exhibited significant increases in both 
basal and LPS-induced expression of IL-1b and TNFa mRNA. The levels of IL-6 mRNA 
did not differ between genotypes.  
Thus, circadian clock malfunction associated with targeted disruption of Per1 and 
Per2 recapitulates macrophage proinflammatory activation induced by overnutrition. 
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Figure 14. Per1/2 disruption increases macrophage proinflammatory activation. 
BMDM were prepared from chow diet-fed wild-type mice and Per1ldc/Per2ldc mice with 
targeted disruption of the clock genes Per1 and Per2 (n = 4 – 6). (A) Representative plots 
of macrophage purity and gating. BMDM were included without (left panel) or with 
(right panel) FITC-labeled anti-F4/80 and APC-labeled anti-CD11b antibodies and 
examined for FITC and APC intensities. (B) BMDM were examined for F4/80 and 
CD11b expression. Mature macrophages (F4/80+ CD11b+ cells) were then gated for 
CD11c and CD206 expression. Panels in (B), representative plots of proinflammatory 
(M1) macrophages (F4/80+ CD11b+ CD11c+ CD206– cells) and anti-inflammatory (M2) 
macrophages (F4/80+ CD11b+ CD11c– CD206+ cells); bar graph in (B), left panel for the 
percentages of M1 macrophages (upper left quadrant of panels in B) in mature 
macrophages and right panel for M2 macrophages (bottom right quadrant of panels in 
B). For bar graphs in (B), data are means ± SE. **, P < 0.01 Per1ldc/Per2ldc vs. wild-
type. 
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Figure 15. Per1/2 disruption increases macrophage proinflammatory responses. 
BMDM were prepared from chow diet-fed wild-type mice and Per1ldc/Per2ldc mice with 
targeted disruption of the clock genes Per1 and Per2 (n = 4 – 6). (A) Macrophage 
inflammatory signaling. Prior to harvest, BMDM were treated with LPS (100 ng/ml) or 
PBS for 30 min. The levels of total and phosphorylated JNK1 (p46) and NF-κB p65 
were examined using Western blot analyses and quantified using densitometry. (B) 
Macrophage mRNA levels of proinflammatory cytokines. Prior to harvest, BMDM were 
treated with LPS (100 ng/ml) or PBS for 6 hr. The mRNA levels of IL-1β, IL-6, and 
TNFα were quantified using real-time PCR and plotted as relative expression. For bar 
graphs, data are means ± SE. *, P < 0.05 and **, P < 0.01 Per1ldc/Per2ldc vs. wild-type 
under the same condition (PBS or LPS). AU, arbitrary units. 
  37 
2.3.4 PPARγ2 overexpression ameliorates Per1/2 disruption-associated macrophage 
proinflammatory activation 
In subsequent mechanistic analyses, we next examined the expression of PPARγ because 
activation of this transcription factor stimulates macrophage alternative (anti-
inflammatory) activation [56, 59], and its promoter region contains multiple E-boxes that 
bind the basic helix-loop-helix protein complexes formed by the core elements of the 
molecular clock brain muscle ARNT-like protein 1 (BMAL1) and circadian locomotor 
output cycles kaput (CLOCK) [80].  
PPARγ protein levels in BMDM from Per1ldc/Per2ldc mice were significantly 
decreased by 40-60% relative to that observed in untreated and control vector-treated 
WT BMDM (Fig. 16). To address the potential involvement of PPARγ in Per1/2 
regulation of macrophage activation, we next determined whether overexpression of 
PPARγ2, one of the two PPARγ  isoforms that effectively mediates PPARγ actions [81], 
ameliorates the inflammatory status of BMDM from Per1ldc/Per2ldc mice. In 
comparison with cultures infected with a control vector, PPARγ2 overexpression in 
Per1ldc/Per2ldc-derived BMDM significantly increased PPARγ content by 2.5-fold (Fig. 
16). 
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Figure 16. Per1/2 disruption decreased PPARγ protein levels. 
BMDM were prepared from chow diet-fed wild-type mice and Per1ldc/Per2ldc mice with 
targeted disruption of the clock genes Per1 and Per2 (n = 4 – 8). Lysates of untreated 
macrophages, as well as PPARγ2-expressing-lentivirus- and/or control-lentivirus-treated 
macrophages were examined for PPARγ content. For the bar graph, PPARγ content was 
examined using Western blot analyses and quantified using densitometry. Per1ldc/Per2ldc 
-BMDM were infected with a lentivirus containing the cDNA of human PPARγ2 or a 
control lentivirus at 6 d after differentiation for 24 hr. Control vector-treated WT 
BMDM were included for comparison. The infected cells were incubated for an 
additional 48 hr and subjected to the pertinent assays. For bar graph, data are means ± 
SE. *, P < 0.05 Per1ldc/Per2ldc vs. wild-type for infected cells; †† P < 0.01 
Per1ldc/Per2ldc +PPARγ2 vs. Per1ldc/Per2ldc. AU, arbitrary units. 
 
 
 
 
Meanwhile, PPARγ2 overexpression in Per1ldc/Per2ldc-derived BMDM 
significantly reduced the phosphorylation of JNK1 and NF-kB p65 (Ser-536) in response 
to LPS-treatment, compared with cultures infected with a control vector (Fig. 17A) 
When expression of inflammatory cytokines was examined, IL-1b and TNFa 
mRNA levels were similar under basal conditions in Per1ldc/Per2ldc controls and 
PPARγ2-overexpressing Per1ldc/Per2ldc BMDM. However, the LPS-mediated 
induction of IL-1b and TNFa, but not IL-6, mRNA levels in PPARγ2-overexpressing 
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Per1ldc/Per2ldc BMDM was significantly decreased relative to that found in control-
treated Per1ldc/Per2ldc BMDM (Fig. 17B). 
 
 
 
 
Figure 17. PPARγ2 overexpression ameliorates Per1/2 disruption-associated 
macrophage proinflammatory activation. 
BMDM were prepared from chow diet-fed wild-type mice and Per1ldc/Per2ldc mice with 
targeted disruption of the clock genes Per1 and Per2 (n = 4 – 8). (A) Macrophage 
inflammatory signaling. Prior to harvest, BMDM were treated with LPS (100 ng/ml) or 
PBS for 30 min. The levels of total and phosphorylated JNK1 (p46) and NF-κB p65 
were examined using Western blot analyses and quantified using densitometry. (B) 
Macrophage levels of IL-1β, IL-6, and TNFα mRNA. Prior to harvest, BMDM were 
treated with LPS (100 ng/ml) or PBS for 6 hr. The mRNA levels of cytokines were 
quantified using real-time PCR and plotted as relative expression. (C) The percentages 
of M1/M2 macrophages were examined using FACS analysis. Per1ldc/Per2ldc -BMDM 
were infected with a lentivirus containing the cDNA of human PPARγ2 or a control 
lentivirus at 6 d after differentiation for 24 hr. Control vector-treated WT BMDM were 
included for comparison. The infected cells were incubated for an additional 48 hr and 
subjected to the pertinent assays. For bar graphs, data are means ± SE. *, P < 0.05 and 
**, P < 0.01 Per1ldc/Per2ldc vs. wild-type for infected cells (C) under the same 
condition (B); †, P < 0.05 and †† P < 0.01 Per1ldc/Per2ldc +PPARγ2 vs. Per1ldc/Per2ldc 
(C) under LPS-treated condition (A and B). AU, arbitrary units. 
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Figure 17 Continued. 
 
 
 
Consistent with these observations, FACS analysis revealed that among analyzed 
mature macrophages, Per1ldc/Per2ldc controls showed a higher percentage of M1 
macrophages compared with WT control cells. Importantly, PPARγ2 overexpression in 
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per1ldc/Per2ldc BMDM induced a significant decrease in the percentage of M1 
macrophages relative to that observed in control-treated cells (Fig. 17C). Among three 
groups of BMDM (control-treated WT, control-treated Per1ldc/Per2ldc, PPARγ2-
overexpressing Per1ldc/Per2ldc), the percentages of M2 macrophages did not differ 
significantly. Thus, PPARγ may play a role in the mechanism by which Per1/2 
disruption up-regulates macrophage proinflammatory activation. 
 
2.3.5 Confirmation of myeloid ccell-specific disruption of Per1/2 
The inflammatory status of macrophages governs the outcome of adipose tissue 
inflammation and thereby systemic insulin sensitivity [58, 60]. To address the impact of 
macrophage-specific circadian clock on HFD-induced adipose tissue inflammation, bone 
marrow cells were isolated from per1ldc/Per2ldc mutant and WT mice and then 
transplanted into lethally irradiated WT recipient (C57BL/6J) mice (BMT) (Fig. 18). 
After HFD feeding for 12 wk and subsequent and metabolic characterization, bone 
marrow cells, BMDM, and adipose-derived SVC as well as adipose and liver tissues 
from chimeric mice were genotyped to identify WT and targeted alleles (Per1, Per2) and 
confirm bone cell repopulation.  
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Figure 18. Bone marrow transplantation to form BMT-WT and BMT-
Per1ldc/Per2ldc chimeric mice. 
 
 
 
In BMT-WT mice (recipients, WT C57BL/6J mice; donors, WT 129J mice), 
genotyping of all genomic DNA samples revealed PCR products for only WT alleles 
(Fig. 19) In contrast, genomic DNA from all of these tissues/cells except BMDM in 
BMT-Per1ldc/Per2ldc mice (recipients, WT C57BL/6J mice; donors, Per1ldc/Per2ldc 
mice) showed PCR products for WT and mutant alleles. Genotyping of BMDM genomic 
DNA from BMT-Per1ldc/Per2ldc mice only yielded PCR products for mutant alleles 
(Fig. 19B). These results demonstrate the success of adoptive transfer of Per1/2-
disrupted myeloid cells to WT recipient mice. 
  43 
 
Figure 19. Confirmation of bone marrow cell repopulation. 
Bone marrow cells from wild-type (WT) 129J mice and Per1ldc/Per2ldc (129J 
background) mice were transplanted into lethally irradiated male WT C57BL/6J mice (at 
5 – 6 wk of age). After recovery for 4 wk, chimeric mice (BMT-WT and BMT- 
Per1ldc/Per2ldc) were fed an HFD for 12 wk. After the feeding regimen, genomic DNA 
was isolated from both isolated cells and tissue samples obtained from all chimeric mice 
and then subjected to PCR genotyping analyses to identify WT and targeted alleles 
(Per1, Per2) and confirm bone cell repopulation. The amplified band of smaller size (~ 
235bp, top panel) signifies the Per1 targeted alleles whereas the PCR product of larger 
size (~ 403bp, bottom panel) denotes the Per2 targeted alleles in (A) Bone marrow cells; 
(B) Bone marrow-derived macrophages (BMDM); (C) Adipose tissue stromal vascular 
cells (SVC); (D) Adipose tissue; and (E) Liver. The confirmation data were generated by 
the collaborator Dr. Earnest’s lab. 
 
 
 
2.3.6 Myeloid cell-specific Per1/2 disruption exacerbates adipose tissue 
inflammation in obesity 
When adipose tissue inflammatory status was examined, the phosphorylation of JNK1 
and NF-kB p65 (Ser-536) in HFD-fed BMT-Per1ldc/Per2ldc mice was significantly 
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increased (Fig. 20A) compared with that in HFD-fed BM-WT. Additionally, adipose 
tissue IL-1b, IL-6 and TNFa mRNA levels in HFD-fed BMT-Per1ldc/Per2ldc mice were 
significantly higher than their respective levels in HFD-fed BMT-WT mice (Fig. 20B), 
whereas BMT genotype had no significant effect on the mRNA levels of arginase 1 and 
IL-10, which are indicative of macrophage alternative activation.  
 
 
 
 
 
 
Figure 20. Myeloid cell-specific Per1/2 disruption exacerbates HFD-induced 
adipose tissue inflammation. 
Chimeric mice (BMT-WT and BMT- Per1ldc/Per2ldc) were fed an HFD for 12 wk (n = 6 
– 10). Prior to tissue collection, mice were fasted for 4 hr starting at the same time of the 
day. (A) Adipose tissue inflammatory signaling. The levels of total and phosphorylated 
JNK1 (p46) and NF-κB p65 were examined using Western blot analyses and quantified 
using densitometry. (B) Adipose tissue expression of genes related to macrophage 
polarization. The mRNA levels of cytokines and arginase1 were quantified using real-
time PCR and plotted as relative expression. For bar graphs, data are means ± SE. *, 
P<0.05 and **, P<0.01 BMT Per1ldc/Per2ldc vs. BMT-WT (A) for the same gene (B). 
AU, arbitrary units. 
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Figure 20 Continued. 
 
 
 
Next, adipose-derived SVC were subjected to FACS analyses. After HFD 
feeding, SVC of BMT-Per1ldc/Per2ldc mice displayed a 1.8-fold increase in mature 
macrophages (F4/80+ CD11b+ cells) compared with those of BMT-WT mice (Fig. 21A). 
Upon analyzing the inflammatory status of the mature macrophages, adipose tissue SVC 
isolated from BMT-Per1ldc/Per2ldc mice showed a 2-fold increase in the overall 
percentage of proinflammatory macrophages (F4/80+ CD11b+ CD11c+ CD206- cells) 
relative to that observed in BMT-WT mice (Fig. 21B). In contrast, the percentage of M2 
macrophages in adipose tissue SVC did not differ between the WT and mutant groups. 
Thus, myeloid cell-specific Per1/2 disruption increases adipose tissue infiltration of 
proinflammatory macrophages, thereby exacerbating HFD-induced adipose tissue 
inflammatory responses. 
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Figure 21. Myeloid cell-specific Per1/2 disruption exacerbates adipose tissue 
macrophages proinflammatory activation. 
Chimeric mice (BMT-WT and BMT- Per1ldc/Per2ldc) were fed an HFD for 12 wk (n = 6 
– 10). Prior to tissue collection, mice were fasted for 4 hr starting at the same time of the 
day. (A) FACS analyses of macrophage infiltration in epididymal fat pads of HFD-fed 
chimeric mice. Left two panels, representative images of adipose tissue stromal vascular 
cells (SVC) that were quantified for F4/80 and CD11b expression; right panel, 
percentages of mature macrophages (F4/80+ CD11b+ cells). (B) Quantification of 
proinflammatory (M1) macrophages (F4/80+ CD11b+ CD11c+ CD206– cells), and anti-
inflammatory (M2) macrophages (F4/80+ CD11b+ CD11c– CD206+ cells) in SVC 
isolated from adipose tissue of HFD-fed chimeric mice. For bar graphs, data are means ± 
SE. **, P<0.01 BMT Per1ldc/Per2ldc vs. BMT-WT. 
 
 
  47 
2.3.7 Myeloid cell-specific Per1/2 disruption exacerbates adiposity and adipose 
tissue dysfunction 
Next, we examined the effects of myeloid cell-specific circadian clock disruption on 
adipose tissue metabolic responses in WT recipients. In response to HFD feeding, BMT-
Per1ldc/Per2ldc mice gained much more abdominal fat mass and displayed a greater 
increase in adiposity than BMT-WT mice (Fig. 22, A and B). Consistent with these 
changes, the size of most adipocytes in adipose tissue was larger in BMT-
Per1ldc/Per2ldc mice than in BMT-WT mice (Fig. 22C)  
Locally, adipose tissue of HFD-fed BMT-Per1ldc/Per2ldc mice showed a 
significant decrease in insulin-induced Akt phosphorylation (Ser-473) relative to that 
observed in HFD-fed BMT-WT mice (Fig. 23A), and this decrease was accompanied by 
decreased adipose tissue expression of mRNAs encoding adiponectin, and adipokine that 
improves systemic insulin sensitivity, and hormone-sensitive lipase (Fig. 23B), a rate-
determining enzyme that controls adipose tissue fat deposition by hydrolyzing 
triglycerides stored in adipose tissue lipid droplets. Compared with HFD-fed BMT-WT 
mice, HFD-fed BMT-Per1ldc/Per2ldc mice also showed a significant increase in adipose 
tissue mRNA levels of resistin, an adipokine that promotes systemic insulin resistance 
(Fig. 23B); although adipose tissue mRNA levels of MCP1, whose increase in 
adipocytes attracts macrophage infiltration, and TLR4, an inflammatory receptor, did not 
differ between HFD-fed BMT-Per1ldc/Per2ldc mice and BMT-WT mice. 
Together, these results indicate that myeloid cell-specific Per1/2 disruption 
potentiates HFD-induced adipose tissue dysfunction. 
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Figure 22. Myeloid cell-specific Per1/2 disruption exacerbates HFD-induced 
adiposity. 
Chimeric mice (BMT-WT and BMT- Per1ldc/Per2ldc) were fed an HFD for 12 wk (n = 6 
– 10). Prior to tissue collection or insulin injection, mice were fasted for 4 hr starting at 
the same time of the day. (A) Adipose mass. Abdominal fat mass was calculated as the 
sum of epididymal, mesenteric, and perinephric fat content. (B) Adiposity was 
calculated by normalizing abdominal fat content to body weight. (C) H&E staining of 
adipose tissue. For bar graphs (A and B), data are means ± SE. *, P < 0.05 and **, P < 
0.01 BMT- Per1ldc/Per2ldc vs. BMT-WT (B) for the same fat pad (A). 
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Figure 23. Myeloid cell-specific Per1/2 disruption exacerbates HFD-induced 
adipose tissue insulin resistance. 
Chimeric mice (BMT-WT and BMT- Per1ldc/Per2ldc) were fed an HFD for 12 wk (n = 6 
– 10). Prior to tissue collection or insulin injection, mice were fasted for 4 hr starting at 
the same time of the day. (A) Adipose tissue insulin signaling. After fasting, HFD-fed 
chimeric mice were given a bolus injection of insulin (1 U/kg body weight) or PBS into 
the portal vein. The levels of total and phosphorylated Akt1/2 were examined using 
Western blot analyses and quantified using densitometry. (B) Adipose tissue gene 
expression. The adipose mRNA levels of genes involved in adipose tissue inflammatory 
and metabolic responses were quantified using real-time PCR and plotted as relative 
expression. For bar graphs (A and B), data are means ± SE. *, P < 0.05 and **, P < 0.01 
BMT- Per1ldc/Per2ldc vs. BMT-WT under the same condition (Insulin in A) or for the 
same gene (B). AU, arbitrary units. 
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2.3.8 Per1/2-disrupted macrophages increase adipocyte inflammatory responses 
and impair adipocyte functions 
Given the critical role of macrophages in initiating or exacerbating adipose tissue 
inflammation, we co-cultured macrophages and adipocytes at a 1:10 ratio to address the 
direct effects of circadian clock disruption on macrophages and/or macrophage factors 
that regulate adipocyte function. Compared with co-cultures containing adipocytes and 
WT BMDM (Adi/WT BMDM), adipocytes cultures with Per1ldc/Per2ldc BMDM 
(Adi/Per1ldc/Per2ldc BMDM) showed a much greater increase in NF-kB p65 (Ser-536) 
phosphorylation in response to LPS treatment (Fig. 24A). 
Adipocytes cultured with Per1ldc/Per2ldc BMDM also exhibited a significant 
increase in IL-1b, IL-6, RNF-a, and resistin mRNA levels and a decrease in adiponectin 
mRNA levels compared with their respective levels in Adi/WT BMDM co-cultures (Fig. 
24B), indicating increased production of pro-insulin resistant and pro-hyperglycemic 
factors.  
When insulin signaling was analyzed, adipocytes cultured with Per1ldc/Per2ldc 
BMDM showed a significant decrease in insulin-induced Akt phosphorylation (Ser-473) 
compared with Adi/WT BMDM co-cultures (Fig. 24C). Taken together, these results 
suggest that Per1/2-disrupted macrophages directly increase adipocyte proinflammatory 
responses and decrease adipocyte insulin sensitivity. 
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Figure 24. Per1/2-disrupted macrophages increase adipocyte inflammatory 
responses and impair adipocyte insulin signaling in co-cultures. 
Adipocytes were co-cultured with macrophages differentiated from bone marrow cells of 
wild-type (Adi/Wild-type) or Per1ldc/Per2ldc mice (Adi/ Per1ldc/Per2ldc) at a 10:1 ratio 
(adipocytes: macrophages) for 48 hr (n = 4–6). (A) NF-κB signaling of co-cultured 
adipocytes. Prior to harvest, adipocyte-macrophage co-cultures were treated with LPS 
(100 ng/ml) or PBS for 30 min. The levels of total and phosphorylated NF-κB p65 were 
examined using Western blot analyses and quantified using densitometry. (B) Cytokine 
and adipokine mRNA levels in co-cultured adipocytes were quantified using real-time 
PCR and plotted as relative expression. (C) Insulin signaling of co-cultured adipocytes. 
Prior to harvest, the co-cultures were treated with insulin (100 nM) or PBS for 30 min. 
The levels of total and phosphorylated Akt1/2 were examined using Western blot 
analyses and quantified using densitometry. For bar graphs, data are means ± SE. *, P < 
0.05 and **, P < 0.01 Adi/ Per1ldc/Per2ldc vs. Adi/Wild-type under the same condition 
(LPS in A; Insulin in C) for the same gene (B). AU, arbitrary units. 
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2.3.9 Myeloid cell-specific Per1/2 disruption exacerbates diet-induced insulin 
resistance and glucose intolerance 
Macrophage-driven adipose tissue inflammation contributes to the development of 
systemic insulin resistance [62, 63]. We examined systemic pathophysiology. Before 
HFD feeding, the body weight of BMT-Per1ldc/Per2ldc mice did not differ from BMT-
WT mice. After HFD feeding, BMT-Per1ldc/Per2ldc mice gained more body weight and 
consumed more food than BMT-WT mice (Fig. 25, A and B). However, feeding 
efficiency did not differ between two groups of chimeric mice (Fig. 25B).  
Compared with HFD-fed BMT-WT mice, HFD-fed BMT-Per1ldc/Per2ldc mice 
exhibited a significant increase in plasma insulin and glucose levels (Fig. 25, C and D); 
however, plasma triglyceride and free fatty acid levels remained unchanged (data not 
shown). In addition, HFD-fed BMT-Per1ldc/Per2ldc mice displayed a significant 
increase in the severity of insulin resistance and glucose intolerance indicated by insulin 
and glucose tolerance testes, respectively (Fig. 25, E and F). Thus, disruption of myeloid 
cell-specific circadian clock mechanism is sufficient to exacerbate HFD-induced insulin 
resistance and metabolic dysregulation. 
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Figure 25. Myeloid cell-specific Per1/2 disruption exacerbates diet-induced insulin 
resistance and glucose intolerance. 
Chimeric mice (BMT-WT and BMT- Per1ldc/Per2ldc) were fed an HFD for 12 wk (n = 6 
– 10). (A) Body weight was monitored before and after HFD feeding. (B) Food intake 
was recorded during the feeding period and calculated as food consumption (g) per day 
per mouse. Right panel, feeding efficiency was calculated as the ratio of food intake to 
body weight. (C) Plasma levels of 19 insulin. (D) Plasma levels of glucose. (E) Insulin 
tolerance tests. (F) Glucose tolerance tests. For A – F, data are means ± SE. *, P < 0.05 
and **, P < 0.01 BMT- Per1ldc/Per2ldc vs. BMT-WT (B – D) under the same condition 
(A) or time point (E and F). For C – F, HFD-fed chimeric mice were fasted for 4 hr 
starting at the same time of the day prior to tissue collection or physiological assays. For 
E and F, mice were given a peritoneal injection of insulin (1 U/kg) (E) or glucose (2 
g/kg) (F). 
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2.3.10 Myeloid cell-specific Per1/2 disruption exacerbates liver inflammatory 
responses, insulin resistance, and metabolic dysregulation 
During obesity, adipose tissue inflammation and dysfunction can produce distal effects 
on liver inflammatory and metabolic responses [77, 82], which in turn also contribute to 
the control of systemic insulin sensitivity and glucose homeostasis. Thus, we used the 
same BMT-WT and BMT-Per1ldc/Per2ldc mice to concurrently analyze the effect of 
myeloid cell-specific circadian clock disruption on liver responses. Compared with 
HFD-fed BMT-WT mice, HFD-fed BMT-Per1ldc/Per2ldc mice exhibited a significant 
increase in liver inflammatory responses, indicated by the increases in the 
phosphorylation of JNK1 (1.7-fold) and NF-kB p65 (2-fold) (Fig. 26A) and in the 
mRNA levels of IL-1b, IL-6, and TNFa (Fig. 26B). 
Meanwhile, HFD-fed BMT-Per1ldc/Per2ldc mice displayed a significant 
increase in the liver weight (Fig. 26C) and a corresponding increase in the severity of 
hepatic steatosis (Fig. 26D).  
When insulin signaling was analyzed, liver tissue from HFD-fed BMT-
Per1ldc/Per2ldc mice showed significant decreases in insulin-induced Akt 
phosphorylation (Ser-473) (Fig. 26E). Consistent with increased severity of hepatic 
steatosis, HFD-fed BMT-Per1ldc/Per2ldc mice were distinguished from controls by a 
significant increase in liver mRNA levels of SREBP1c and FAS, which are, respectively, 
a critical transcription factor and a lipogenic enzyme that promotes lipogenesis and 
hepatic steatosis (Fig. 26F) relative to that found in control mice.  These results indicate 
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that similar to adipose tissue, HFD-induced liver metabolic dysregulation is amplified by 
myeloid cell-specific Per1/2 disruption. 
 
 
 
 
 
 
Figure 26. Myeloid cell-specific Per1/2 disruption exacerbates HFD-induced liver 
inflammatory responses and insulin resistance. 
Chimeric mice (BMT-WT and BMT- Per1ldc/Per2ldc) were fed an HFD for 12 wk (n = 6 
– 10). (A) Liver inflammatory signaling. The levels of total and phosphorylated JNK1 
(p46) and NF-κB p65 were examined using Western blot analyses and quantified using 
densitometry. (B) Liver levels of proinflammatory cytokine mRNAs. (C) Liver weight. 
(D) Liver histology (H&E staining). (E) Liver insulin signaling. (F) Liver mRNA levels 
of key metabolic genes. For A – F, HFD-fed chimeric mice were fasted for 4 hr starting 
at the same time of the day prior to tissue collection (A – D, and F) or insulin injection 
(E). For B and F, liver mRNA levels of metabolic genes were quantified using real-time 
PCR and plotted as relative expression. For E, chimeric mice were given a bolus 
injection of insulin (1 U/kg body weight) or PBS into the portal vein. For bar graphs (A 
– C, E, and F), data are means ± SE. *, P < 0.05 and **, P < 0.01 BMT- Per1ldc/Per2ldc 
vs. BMT-WT (A – C) under same condition (Insulin in E) for the same gene (F). AU, 
arbitrary units. 
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Figure 26 Continued. 
 
 
 
2.4 Discussion 
During obesity, macrophage proinflammatory activation initiates or aggravates 
inflammation in key metabolic organs including adipose and liver tissues, thereby 
leading to systemic insulin resistance. However, it remains to be elucidated exactly how 
overnutrition induces proinflammatory activation of macrophages, particularly in those 
found in adipose tissue where increased inflammation plays a causal role in the 
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pathogenesis of insulin resistance [10, 12, 42-44]. In parallel with this inductive effect 
on macrophage proinflammatory activation [12],HFD feeding has been shown to 
decrease the amplitude of adipose tissue clock gene rhythms in Bmal1, Clock, and Per 2 
expression [28] and to lengthen the period of the Per2 rhythm in cultured adipose tissue 
[31]. Taken together, these observations suggest that dysregulation of peripheral 
circadian clocks may link diet-associated obesity to adipose tissue inflammation. In 
support of this putative association, the present study demonstrates that in HFD-fed mice 
where minor increases in period of the activity of rhythm were similar to those observed 
previously [28], overnutrition caused dysregulation of peripheral circadian clocks (i.e. 
substantial increases in the period of Per 2 oscillations) specifically within key 
mediators of adipose tissue inflammation, macrophages in stromal vascular cells, and 
BMDM. Furthermore, the diet-related clock dysregulation in BMDM was accompanied 
by increased proinflammatory activation. It is noteworthy that our findings provide 
evidence for the direct link between circadian clock dysregulation and macrophage 
proinflammatory activation in diet-induced obesity. Specifically, clock-disrupted 
(Per1ldc/Per2ldc) macrophages are distinguished by enhanced proinflammatory 
activation, and myeloid cell-specific clock disruption (Per1ldc/Per2ldc) exacerbates diet-
induced inflammation and insulin resistance in chimeric mice repopulated with only 
mutant bone marrow cells. As such, the current study indicates for the first time that 
dysregulation of the macrophage circadian clock (e.g. Per1/2 disruption) is a critical 
factor in the mechanism through which overnutrition induces macrophage 
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proinflammatory activation, thereby leading to adipose tissue inflammation in the 
context of systemic insulin resistance and hyperglycemia. 
Per1 and Per2 are vital components of the circadian clock mechanism and 
function as negative regulators in feedback loops involving interactions between Bmal1, 
Clock, and the cryptochrome (Cry1 and Cry2) genes [29]. Previously, genetic or 
environmental disruption of circadian clock function has been shown to alter 
macrophage proinflammatory responses. In macrophages, conditional targeting of 
Bmal1 abolishes the rhythmic gating of innate immune responses such that cytokine 
responsiveness to LPS stimulation remains constantly elevated [68]. Environmental 
disruption of circadian rhythms after weekly 6-h shifts in the light-dark cycle similarly 
exacerbates inflammatory responses of peritoneal macrophages to LPS challenge in the 
absence of sleep loss or stress effects [69]. In the present analysis of Per1ldc/Per2ldc 
mice that are characterized by a globally arrhythmic phenotype [71], circadian clock 
dysfunction did not influence macrophage differentiation, as the percentage of mature 
macrophages (F4/80+ CD11b+  cells) differentiated from bone marrow cells of 
Per1ldc/Per2ldc mice was identical to that found in wild-type mice. However, among 
mature macrophages, Per1/2-disrupted cells showed a much higher percentage of 
CD11c+ CD206- cells, indicating increased macrophage proinflammatory activation. The 
macrophage inflammatory status was corroborated by the finding that Per1/2 disruption 
increased JNK1 and NF-κB p65 phosphorylation and IL-1β and TNFα expression in 
mature macrophages under LPS-stimulated conditions. Thus, Per1/2 disruption-
associated circadian dysfunction increases macrophage proinflammatory activation. 
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How the Per1 and Per2 genes regulate macrophage activation remains to be determined. 
It is possible that Per1 and Per2 modify inflammatory gene expression through their 
feedback regulation of CLOCK/BMAL1 transcriptional activity. Indeed, CLOCK has 
been shown to function as a positive regulator of the transcription factor NF-κB, which 
is a critical determinant of inflammatory responses [83]. Consequently, the relative 
increases in CLOCK levels observed in peripheral tissues from mutant mice (data not 
shown) suggest that the loss of negative feedback regulation resulting from Per1/2 
disruption may further enhance the activation of NF-κB and ultimately the induction of 
NF-κB responsive genes such as IL-1β, TNFα, and other cytokines. Alternatively, Per1 
and Per2 may alter macrophage inflammatory signaling through interactions with other 
components of the core or auxiliary feedback loops comprising the molecular 
clockworks because REV-ERBα has been shown to modulate macrophage TLR 
signaling [84] and function as an inhibitor of proinflammatory IL-6 release [68]. Given 
that active PPARγ promotes macrophage anti-inflammatory activation [56, 59, 85] and 
this transcription factor is a molecular target of insulin-sensitizing and anti-diabetic 
drugs [86], PPARγ may play a role in Per1/2 regulation of macrophage activation. In 
fact, our data support this hypothesis because PPARγ levels were decreased in Per1/2-
disrupted macrophages in conjunction with their enhanced proinflammatory activation 
and PPARγ 2 overexpression reversed, at least in part, this Per1/2 disruption-associated 
shift in inflammatory status. Collectively, these observations suggest a novel mechanism 
for macrophage polarization in which the circadian clock normally acts through PPARγ 
to inhibit macrophage proinflammatory activation. Because the PPARγ promoter 
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contains multiple E-boxes [80], it will be important to determine whether negative 
feedback by Per1 and/or Per2 modulates CLOCK/BMAL1 regulation of E-box 
mediated transcription of PPARγ. 
The significance of circadian clock function in macrophage activation was 
further manifested by the finding that adoptive transfer of Per1/2-disrupted myeloid cells 
to wild-type mice exacerbated HFD-induced inflammation and insulin resistance. 
Notably, BMT-Per1ldc/Per2ldc mice displayed marked increases in adipose tissue 
inflammatory responses as indicated by enrichment of mature proinflammatory 
macrophages in adipose tissue and increased inflammatory signaling and 
proinflammatory cytokine expression. Consequently, inflammation associated adipose 
tissue dysfunction (i.e. decreased insulin signaling and adipose tissue metabolic 
dysregulation) was markedly increased in BMT-Per1ldc/Per2ldc mice. Given the origin of 
the myeloid cells/macrophages, the increased severity of adipose tissue inflammatory 
responses and dysfunction in BMT-Per1ldc/Per2ldc mice solely reflects proinflammatory 
activation in clock-disrupted macrophages. This relation was substantiated by the finding 
that co-culture of adipocytes with Per1/2-disrupted macrophages increased adipocyte 
inflammatory response and decreased adipocyte insulin sensitivity. In similar fashion, 
Per1/2-disrupted macrophages appeared to mediate the increased severity of liver 
inflammatory responses and metabolic dysregulation. Altogether, these observations 
provide convincing evidence that macrophage circadian clock dysregulation is sufficient 
to potentiate overnutrition-induced inflammation in adipose tissue and the liver, thereby 
increasing systemic insulin resistance. 
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In summary, the present data unveil a novel mechanism for obesity-associated insulin 
resistance in which circadian clock dysregulation is a key factor that links overnutrition 
and macrophage proinflammatory activation to adipose tissue inflammation. At the 
cellular level, HFD-associated overnutrition modulates circadian clock function in 
macrophages, which in turn induces the proinflammatory activation of macrophages, 
especially those in adipose tissue. When activated, clock-disrupted macrophages are 
sufficient to exacerbate diet induced adipose tissue inflammation and systemic insulin 
resistance. Because adipose tissue inflammatory responses and corresponding insulin 
sensitivity in overnutrition-related obesity are differentially engaged by specific types of 
fatty acids found in HFDs, future studies are warranted to compare the effects of 
saturated and polyunsaturated fatty acids on macrophage and adipocyte circadian clocks. 
Thus, it will be important to determine whether saturated fatty acids that activate 
proinflammatory signaling pathways and lead to impaired insulin sensitivity (e.g. 
palmitate) also modulate the circadian timekeeping function of macrophage and 
adipocyte clocks and whether this circadian clock dysregulation is blocked or abated by 
polyunsaturated fatty acids that repress adipose tissue inflammatory responses and have 
a beneficial impact on insulin sensitivity. 
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3. PFKFB3 CONTROL OF MACROPHAGE ACTIVATION 
3.1 Introduction 
Chronic diseases are the leading causes of morbidity and mortality in the United States 
[87, 88]. The current body of knowledge suggests a critical role for macrophages in the 
control of systemic insulin resistance associated with chronic diseases [3, 4]. 
Overnutrition is a key causal factor that contributes to chronic metabolic disorders 
largely by induction of macrophage proinflammatory activation, however, the exact 
mechanisms by which nutrient metabolism regulates macrophage inflammatory status 
are poorly understood [11-15]. This opens up an area for overnutrition induced systemic 
insulin resistance prevention and/or treatment by means of altering macrophage 
inflammatory status.  
PFKFB3, encoding for inducible 6-phosphofructo-2-kinase (iPFK2), is proposed 
to be a critical modulator of macrophage inflammatory status. As a key regulatory 
enzyme of glycolysis, PFKFB3/iPFK2 is also involved in the effect of PPARγ activation 
and appears play a role in macrophage activation [15]. Additionally, our lab has 
demonstrated that global PFKFB3 disruption exacerbates expression of proinflammatory 
cytokines such as TNFα and IL-6 in adipose tissue macrophages as well as adipocytes 
[10]. As such, elucidating the role of PFKFB3/iPFK2 in controlling the M1/M2 
macrophage balance can contribute significantly to a better understanding of the 
underlying mechanisms of overnutrition-induced insulin resistance. This could offer 
better strategies for prevention and/or treatment of obesity-related diseases.   
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In this study, both integrative and cellular approaches were included to define a 
pivotal role played by PFKFB3 in modulating macrophages inflammatory properties. 
Our hypothesis is that PFKFB3 disruption enhances macrophage proinflammatory 
activation in diet-induced obesity, resulting in local and systemic insulin resistance. To 
test this hypothesis, we conducted a series of experiments to determine whether 1) 
disruption of PFKFB3 exacerbates macrophage proinflammatory activation (in vitro), 2) 
myeloid cell-specific disruption of PFKFB3 exacerbates diet-induced inflammation and 
insulin resistance (in vivo), and 3) PFKFB3-disrupted macrophage exacerbates 
adipocytes inflammatory responses and insulin resistance. 
 
3.2 Materials and Methods 
3.2.1 Animal experiments 
Animals used in this study were derived from wild-type (WT) C57BL/6J mice obtained 
from The Jackson Laboratory (Bar Harbor, ME) and from breeding pairs of WT and 
PFKFB3+/- mice generated as previously described (Homozygous disruption of 
PFKFB3/iPFK2 is embryonic lethal)[89]. All mice were maintained on a 12:12-h light-
dark cycle (lights on at 06:00). All mice were fed chow diet ad libitum except those that 
were used for dietary feeding study. At the age of 5-6 wk, male mice were used for both 
feeding and bone marrow isolation and macrophage activation analyses. For dietary 
feeding studies, mice were fed an high fat diet (HFD, 60% fat calories, 20% protein 
calories, and 20% carbohydrate calories) or a low fat diet (LFD, 10% fat calories, 20% 
protein calories, and 70% carbohydrate calories; Research Diets, Inc.) for 12 wk as 
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previously described[10, 44] (nutrient composition listed in Table. 1). During the 12-wk 
feeding period, body weight and food intake of the mice were recorded every week. 
After the feeding regimen, mice were fasted for 4 h before sacrifice for collection of 
blood and tissue samples [72, 73, 90]. Epididymal, mesenteric, and perinephric fat 
depots were dissected and weighted as visceral fat content[73]. After weighing, adipose 
tissue and liver samples were either fixed and embedded for histological and 
immunohisto-chemical analyses or frozen in liquid nitrogen and then stored at -80 °C for 
further analyses. Some mice were fasted similarly and used for insulin and glucose 
tolerance tests and /or insulin signaling analyses as described below. All study protocols 
were reviewed and approved by the Institutional Animal Care and Use Committee of 
Texas A&M University. 
 
3.2.2 Determination of PFKFB3 mRNA and iPFK2 amount 
PFKFB3 mRNA and iPFK2 amount in the adipose tissue and macrophages were 
determined using real-time PCR and Western blot, respectively, as described below. 
 
3.2.3 Glucose and insulin tolerance tests 
Glucose and Insulin tolerance tests were performed as previously described [91]. Mice 
were fasted for 4 h and intraperitoneally injected with D-glucose (2 g/kg of body weight) 
or insulin (1 unit/kg of body weight). For glucose tolerance tests, blood samples (5 ul) 
were collected from the tail vein before and at 30, 60, 90, and 120 min after the glucose 
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bolus injection. Similarly, for insulin tolerance tests, blood samples were collected from 
the tail vein before and at 15, 30, 45, 60 min after the bolus insulin injection. 
 
3.2.4 Measurement of plasma glucose and insulin 
The levels of plasma glucose were measured using glucose assay kit (Sigma and 
BioVision, Mountain View, CA). The levels of plasma insulin were measured using 
ELISA kits (Crystal Chem Inc., Downers Grove, IL). 
 
3.2.5 Measurement of rates of glycolysis 
Each well (6-well plate) of macrophages were incubated with medium supplemented 
with 1 µCi [3-3H]-glucose for 3 h. After incubation, the medium was collected to 
determine the production of 3H2O (in disintegration per minute (DPM)) as described 
[92]. Two sets of medium were collected after 3 hr incubation. One set was used to 
measure total DMP, which equals 3H2O plus the left 3H-glucose and other non-H2O 
metabolites. The other set was used air dry, and measured leftover DPM. The differences 
give the DPM of 3H2O. Rates of glycolysis are expressed as nanomoles of glucose 
metabolized per 3 h per milligram of protein.  
 
3.2.6 Histological and immunohisto-chemical analyses of adipose tissue 
The paraffin-embedded adipose tissue blocks were cut into sections of 5-µm thickness 
and stained with hematoxylin and eosin. In addition, the sections were stained for the 
expression of F4/80 with rabbit anti-F4/80 (1:100) (AbD Serotec, Raleigh, NC) as 
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previously described [42, 93]. The fraction of F4/80-expressing cells for each sample is 
calculated as the sum of the number of nuclei of F4/80-expressing cells divided by the 
total number of nuclei in sections of a sample. Six fields per slide were included, and a 
total of 4-6 mice per group were used. 
 
3.2.7 Isolation of stromal vascular cells (macrophages) from adipose tissue 
Adipose tissue stromal vascular cells (SVCs) and adipocytes were isolated using the 
collagenase digestion method as previously described [56]. After digestion and 
centrifugation, the pelleted cells were collected as SVCs, and the floating cells were 
harvested as adipocytes.  
 
3.2.8 Bone marrow isolation and macrophage differentiation 
Bone marrow cells were isolated from the tibias and femurs of the WT mice as 
previously described [59, 62]. After erythrocyte lysis with ammonium chloride (Stem 
Cell Technologies), cells were induced for differentiation with Iscove’s modified 
Dulbecco’s medium containing 10% fetal bovine serum and 15% L929 culture 
supernatant for 8 d. The bone marrow-derived macrophages (BMDMs) were subjected 
to inflammatory response analysis and co-culture study.  
 
3.2.9 Co-culture of macrophages and adipocytes 
BMDMs prepared from PFKFB3+/- or WT mice were co-cultured with differentiated 
3T3-L1 adipocytes as previously described [60, 91]. After differentiation for 8 d, 
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adipocytes were co-cultured with BMDMs at a ratio of 10:1 based on the published 
method [60, 94]. To determine changes in inflammatory signaling, some cells were 
treated with or without LPS (100 ng/ml) for 30 min before cell harvest. To examine 
changes in insulin signaling, some cells were treated with or without insulin (100 
nmol/L) for 30 minutes before harvest. Cell lysates were prepared and used to examine 
inflammatory and insulin signaling by Western blots. Additionally, some co-cultured 
cells were treated with or without LPS (100 ng/ml) for 6 h and subjected to preparation 
of RNA samples to quantify gene expression using real-time PCR.  
 
3.2.10 Bone marrow transplantation 
Bone marrow transplantation analyses were performed as previously described [91]. 6-
wk-old PFKFB3+/- male mice or WT littermates were used as donor. Male WT recipient 
mice at 5-6 wk of age were lethally irradiated and subjected to BMT to generate 
chimeric mice using the established method [60, 61]. WT mice that were transplanted 
with donor cells from PFKFB3+/- mice were referred to as BMT-PRKRB+/- mice. WT 
mice that were transplanted with donor cells from WT mice were referred to as BMT-
WT mice. After recovery for 4 wk, recipient mice were then fed an HFD for 12 wk 
before metabolic assays and tissue collections. All study protocols were reviewed and 
approved by the Institutional Animal Care and Use Committee of Texas A&M 
University.  
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3.2.11 Western blots 
Lysates were prepared from frozen tissue samples and cultured cells. Western blots were 
conducted as previously described [91]. The levels of protein iPFK2, JNK1/2, phosphor-
JNK1/2, nuclear factor kB (NF-κB) p65, hospho-p65, Akt, phosphor-Akt, and PPARγ in 
cell lysates were analyzed. GAPDH or b-actin was used as a loading control. The 
maximum intensity of each band was quantified using ImageJ software. Ratio of 
pJNK1/JNK1 and phosphor-p65/p65 as well as phosphor-Akt/Akt were normalized to 
GAPDH or b-actin and adjusted relative to the average of control (PBS)-treated LFD, 
WT, BMT-WT, or Adi/WT, which was arbitrarily set as 1 (arbitrary units, AU). 
 
3.2.12 RNA isolation, reverse transcription, and real-time PCR 
The total RNA was isolated from frozen tissue samples and culture/isolated cells. RNA 
isolation and real-time RT-PCR were conducted as previously described [91]. Reverse 
transcription was performed using the GoScriptTM Reverse Transcription System 
(Promega), and real-time PCR analysis was performed using SYBR Green (LightCycler 
® 480 system; Roche Life Science, Indianapolis, IN). The mRNA levels were analyzed 
for interleukin-1b (IL-1β), IL-6, tumor necrosis factor a (TNFα), IL-10, arginase1, 
monocyte chemoattractant protein 1 (MCP1), TLR4, adiponectin, and PFKFB3 in tissue 
and/or cell samples. A total of 0.1 ug of RNA was used for the determination. Results 
were normalized to 18 S ribosomal RNA and plotted as relative expression to the 
average of control (PBS)-treated LFD, WT, BMT-WT, or Adi/WT, which was arbitrarily 
set as 1. 
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3.2.13 Statistical methods 
Numeric data are presented as means ± S.E. Statistical significance was assessed by 
unpaired, two-tailed analysis of variance or Student’s t test. Differences were considered 
significant at the two-tailed p<0.05. 
 
3.3 Results 
3.3.1 PFKFB3 disruption decreases glycolysis in macrophages 
At 5-6 wk of age, bone marrow cells were isolated from chow diet-fed male PFKFB3+/- 
mice and WT littermates.  Bone marrow cells (BMC) and differentiated BMDM were 
used to measure the expression of PFKFB3. Compared to BMDM from WT controls, 
BMC and BMDM from PFKFB3+/- mice exhibited decreased PFKFB3 mRNA level 
(Fig. 27, A and B). Consistently, in PFKFB3 disrupted BMDM, the rate of glycolysis 
decreased significantly compared to WT macrophages (Fig. 27C).   
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Figure 27. PFKFB3 disruption decreases glycolysis in macrophages. 
BMC and BMDM were prepared from chow diet-fed wild-type mice and PFKFB3+/- 
mice with targeted disruption of heterozygous disruption of the gene PFKFB3 (n=3-6). 
(A) BMC mRNA level of PFKFB3. (B) BMDM mRNA level of PFKFB3. (C) Relative 
rates of glycolysis. For bar graphs, data are means ±SE. *, P< 0.05 PFKFB3+/- vs. wild-
type. 
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3.3.2 PFKFB3 disruption exacerbates macrophage proinflammatory activation and 
impairs macrophage alternative activation 
When inflammatory responses were analyzed, BMDM from PFKFB3+/– mice exhibited a 
significant increase in the phosphorylation of NF-κB compared with BMDM from wild-
type littermates (Fig. 28A). 
Moreover, upon LPS stimulation, the BMDM M1 (proinflammatory) activation 
differed in accord with genotype. Under both basal and LPS-treated conditions, the 
mRNA levels of TNFα and IL-6 in PFKFB3+/– BMDM were significantly higher than 
their respective levels in WT BMDM, indicating that PFKFB3 disruption exacerbates 
macrophage proinflammatory activation (Fig. 28B). Upon IL-4 stimulation for BMDM 
M2 (anti-inflammatory) activation, under both basal and treated conditions, the mRNA 
levels of IL-6 and IL-1β in PFKFB3+/– BMDM were significantly higher than their 
respective levels in WT BMDM, indicating that PFKFB3 disruption hinders macrophage 
anti-inflammatory activation (Fig. 28C). The similar pattern was also observed in 
peritoneal macrophages when treated IL-4 (data not shown). 
 
3.3.3 Myeloid cell-specific PFKFB3 disruption does not worsen diet-induced obesity  
Macrophage inflammatory status governs adipose inflammation and contributes to the 
development of systemic insulin resistance [58, 60]. To address the impact of 
macrophage specific PFKFB3 on HFD-induced adipose tissue inflammation, Bone 
marrow cells of PFKFB3-disrupted mice and/or wild-type littermates were transplanted 
into lethally irradiated wild-type mice (BMT), noted as BMT- PFKFB3+/- mice 
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Figure 28. PFKFB3 disruption exacerbates macrophage proinflammatory 
activation and impairs macrophage alternative activation. 
BMDM were prepared from chow diet-fed wild-type mice and PFKFB3+/- mice with 
targeted disruption of heterozygous disruption of the gene PFKFB3 (n=3-6). (A) The 
phosphorylation of NF-κB p65, examined using western blot and quantified using 
Image-J. (B) The mRNA levels of proinflammatory cytokines. BMDM were treated with 
LPS (100 ng/ml) or PBS for 6h. The mRNA levels of TNFα and IL-6 were quantified 
using real-time PCR and plotted as relative expression. (C) The mRNA levels of anti-
inflammatory cytokines. BMDM were treated with IL-4 (10 ng/ml) or PBS for 48 h. The 
mRNA levels of IL-6 and IL-1β were quantified using real-time PCR and plotted as 
relative expression. For bar graphs, data are means ±SE. *, P< 0.05; **, P< 0.01; and 
***, P< 0.001 PFKFB3+/- vs. wild-type (A) under the same conditions (B, PBS or LPS; 
C, PBS or IL-4); †, P< 0.05; ††, P< 0.01; †††, P< 0.001 LPS vs. PBS (B) or IL-4 vs. 
PBS (C) for the same genotype. AU, arbitrary units. 
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 (PFKFB3+/- àWT) and BMT-WT mice (WTàWT) respectively. After one month of 
recovery, the mice were fed with HFD for 12 wk.  
Before and after HFD feeding, the body weight of BMT- PFKFB3+/- mice did not 
differ from BMT-WT mice. Mice in both groups gained similar body weight (Fig. 29A) 
and displayed comparable abdominal fat mass (Fig. 29B).  
 
 
 
 
 
Figure 29. Myeloid cell-specific PFKFB3 disruption did not alter diet-induced 
obesity. 
Chimeric mice BMT-WT (WTàWT) and BMT- PFKFB3+/- (PFKFB3+/- àWT) were 
fed an HFD for 12 wk (n=7-10). (A) Body weight was monitored before and after HFD 
feeding. (B) Adipose mass. Abdominal fat mass (visceral fat) was the sum of 
epididymal, mesenteric and perinephric fat mass. Data are means ±SE. For B HFD-fed 
chimeric mice were fasted for 4h starting at the same time of the day before tissue 
collection. 
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3.3.4 Myeloid cell-specific PFKFB3 disruption exacerbates diet-induced systemic 
insulin resistance 
Even with comparable adiposity, HFD-fed BMT- PFKFB3+/- mice exhibited a significant 
increase in plasma insulin and glucose levels, compared with HFD-fed BMT-WT mice 
(Fig. 30, A and B). In addition, HFD-fed BMT- PFKFB3+/- mice displayed a significant 
increase in the severity of insulin resistance and glucose intolerance indicated by insulin 
and glucose tolerance testes, respectively (Fig. 30, C and D). Thus, myeloid cell-specific 
PFKFB3 disruption does not alter adiposity after HFD feeding, but exacerbates systemic 
insulin resistance. 
 
3.3.5 Myeloid cell-specific PFKFB3 disruption exacerbates diet-induced adipose 
tissue inflammation and insulin resistance 
Immunohisto-chemical analysis of adipose tissue sections suggested that there was more 
macrophage infiltration in adipose tissue from BMT- PFKFB3+/- mice compared with 
that in adipose tissue from BMT-WT mice (Fig. 31A). When inflammatory status was 
examined in adipose tissue, the phosphorylation of NF-κB p65 was increased 
significantly in BMT- PFKFB3+/- mice compared with BMT-WT mice, both fed with 
HFD (Fig. 31B). Accordingly, BMT- PFKFB3+/- mice displayed decreased insulin 
sensitivity evidenced by decreased insulin-induced phosphorylation of Akt, when 
compared with BMT-WT mice (Fig. 31C). Thus, myeloid cell-specific PFKFB3 
disruption increases macrophage infiltration in adipose tissue and inflammatory 
responses, and meanwhile exacerbates HFD-induced adipose tissue insulin resistance. 
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Figure 30. Myeloid cell-specific PFKFB3 disruption exacerbates diet-induced 
insulin resistance and glucose intolerance. 
Chimeric mice BMT-WT (WTàWT) and BMT- PFKFB3+/- (PFKFB3+/- àWT) were 
fed an HFD for 12 wk (n=7-10). (A) Plasma levels of insulin. (B) Plasma levels of 
glucose. (C) Insulin tolerance test. (D) Glucose tolerance test. Data are means ±SE. *, P< 
0.05; and **, P< 0.01 BMT- PFKFB3+/- vs. BMT-WT under the same conditions (A and 
B) or time points (C and D). HFD-fed chimeric mice were fasted for 4h starting at the 
same time of the day before tissue collection or physiological assays. For C and D, mice 
were given a peritoneal injection of insulin (1 unit/kg) (C) or glucose (2g/kg) (D). 
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Figure 31. Myeloid cell-specific PFKFB3 disruption exacerbates obesity-associated 
adipose tissue inflammation and insulin resistance. 
Chimeric mice BMT-WT (WTàWT) and BMT- PFKFB3+/- (PFKFB3+/- àWT) were 
fed an HFD for 12 wk (n=7-10). Before tissue collection or insulin injection, mice were 
fasted for 4h starting at the same time of the day. (A) F4/80 staining of adipose tissue. 
(B) Adipose tissue inflammatory signaling. The levels of total and phosphorylated NF-
κB p65 were examined using western blot and quantified using Image-J. (C) Adipose 
tissue insulin signaling. After fasting, HFD-fed chimeric mice were given a bolus 
injection of insulin (1 unit/kg of body weight) or PBS into the portal vein. The levels of 
total and phosphorylated Akt were examined using western blot analyses and quantified 
by Image-J. For bar graphs (B), data are means ±SE. **, P< 0.01 BMT- PFKFB3+/- vs. 
BMT-WT. AU, arbitrary units. 
 
 
 
Similarly, we observed significant increase of NF-κB p65 phosphorylation in 
liver from BMT- PFKFB3+/- mice compared with that in liver from BMT-WT mice (data 
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not shown). Additionally, insulin-induced phosphorylation of Akt decreased 
significantly in liver from BMT- PFKFB3+/- mice compared with that in liver from 
BMT-WT mice (data not shown). Thus, myeloid cell-specific PFKFB3 disruption 
increases liver inflammatory responses and impaired HFD-induced liver insulin 
sensitivity. 
 
3.3.6 PFKFB3-disrupted macrophages increase adipocyte inflammatory responses 
and impair adipocyte insulin signaling 
As macrophages play a pivotal role in initiating or exacerbating adipose tissue 
inflammation, next we wanted to address the direct effects of PFKFB3 disruption on 
macrophages and/or macrophage secreted factors that regulate adipocyte function. 
BMDM from PFKFB3+/- mice and WT mice were co-cultured with adipocytes at a 1:10 
ratio, respectively. Compared with co-cultures containing adipocytes and WT BMDM, 
adipocytes co-cultured with PFKFB3+/- BMDM exhibited a significant increase in the 
phosphorylation of NF-κB p65 and JNK in response to LPS treatment (Fig. 32A). When 
insulin signaling was analyzed, adipocytes co-cultured with PFKFB3+/- BMDM 
displayed a significant decrease in Akt phosphorylation (Ser473) induced by insulin 
compared with adipocytes co-cultured with WT BMDM (Fig. 32B). These results 
suggest that PFKFB3-disrupted macrophages directly increase adipocyte 
proinflammatory responses and decrease adipocyte insulin sensitivity. 
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Figure 32. PFKFB3-disrupted macrophages increase adipocyte inflammatory 
responses and impair adipocyte insulin signaling. 
Adipocytes were co-cultured with macrophages differentiated from bone marrow cells of 
wild-type or PFKFB3+/- mice at a 10:1 ratio for 48 h (n=4-6). (A) NF-κB and JNK 
signaling of co-cultured adipocytes. Co-cultures were treated with LPS (100 ng/ml) or 
PBS for 30 min before harvest. The levels of total and phosphorylated JNK1 (p46) and 
NF-κB p65 were examined using western blot analyses and quantified using Image-J. 
(B) Insulin signaling of co-cultured adipocytes. Co-cultures were treated with insulin 
(100 nM) or PBS for 30 min before harvest. The levels of total and phosphorylated Akt 
were examined using western blot and quantified by Image-J. For bar graphs (B), data 
are means ±SE. *, P< 0.05 Adi/ PFKFB3+/- vs. Adi/wild-type under the same conditions 
(insulin). 
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3.4 Discussion 
In diet-induced obesity (DIO), macrophage proinflammation activation is a key 
contributor to the inflammation in key metabolic organs including adipose and liver 
tissues, resulting in systemic insulin resistance.  Therefore, research has been widely 
conducted recently in the attempt to discover modulators of macrophage activation so as 
to control the inflammation and pathogenesis of insulin resistance. For example, it has 
been demonstrated that circadian control of macrophage activation plays an important 
role in diet-induced inflammation and insulin resistance [91]; miR-223 has been proved 
to be a regulator of macrophage activation in obesity-associated adipose tissue 
inflammation [95]. Interestingly, our previous research has suggested that PFKFB3 
protects mice against diet-induced inflammation and insulin resistance [10, 77], and 
FKFB3 gene happens to be a circadian controlled gene. Thus, PFKFB3 is a good 
candidate to test if it is another modulator of macrophage activation. 
In HFD-fed WT mice, PFKFB3 expression in adipose tissue decreased (data not 
shown) and inflammation increased at the same time, compared with LFD-fed WT mice. 
To test the causal effect, macrophages from PFKFB3-disrupted mice were examined. 
Compared to WT macrophages, PFKFB3-disrupted macrophages displayed higher 
proinflammatory activation and lower anti-inflammatory activation. Thus, PFKFB3 
disruption directly affects macrophage activation and inflammatory status. Whether 
PFKFB3-disruption in macrophage is sufficient enough to bring about adipose tissue 
inflammation and systemic insulin resistance was investigated by bone marrow 
transplantation. We generated myeloid-specific PFKFB3-disrupted mice through BMT. 
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After HFD feeding, the adiposity in BMT- PFKFB3+/- mice was comparable with BMT-
WT mice. However, we observed increased macrophage infiltration in adipose tissue, 
elevated inflammatory responses in adipose tissue and exacerbated systemic insulin 
resistance in BMT- PFKFB3+/- mice compared to BMT-WT mice. The following co-
culture study suggested a direct effect of macrophage PFKFB3 disruption on 
exacerbating adipocytes inflammatory responses and insulin resistance. 
How the PFKFB3 gene regulates macrophage activation status remains to be 
further determined. It is possible that when PFKFB3 is disrupted in macrophage, the rate 
of glycolysis decreases and ROS production increases, which in turn contribute to the 
proinflammatory responses in macrophages. The present study gained new insights of 
the role of PFKFB3 in regulating macrophage inflammatory status, and will provide 
essential information for the development of selective PFKFB3 activators in the 
prevention and/or treatment of overnutrition-induced systemic insulin resistance. 
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4. SUMMARY AND CONCLUSION 
4.1 Summary 
Macrophage activation status plays a critical role in chronic inflammation associated 
with obesity and insulin resistance. The presented study investigated the ways to 
modulate macrophage activation from circadian aspect and metabolic aspect in diet-
induced obesity. 
Upon HFD feeding, mice developed exacerbated adiposity, adipose tissue 
inflammation, systemic insulin resistance and circadian dysregulation. Interestingly, 
macrophages from HFD-fed mice also displayed increased circadian dysregulation and 
inflammatory responses compared to LFD-fed group. To address a direct role for 
circadian clock disruption in altering macrophage activation status, BMDM prepared 
from Per1/Per2-disrupted mice were examined. Compared to control cells, the 
Per1/Per2-disrupted macrophages exhibited a marked increase in proinflammatory 
activation (M1) even though maintaining comparable percentage of anti-inflammatory 
activation, which resulted in a significant increase of inflammatory signaling and 
proinflammatory cytokines expression. Meanwhile, PPARγ expression was decreased in 
Per1/Per2-disrupted macrophages, and overexpression of PPARγ2 rescued the 
exacerbated inflammatory status in Per1/Per2-disrupted macrophages. Next, in vivo 
BMT study was conducted to test if macrophage Per1/Per2 disruption is sufficient 
enough to bring about systemic insulin resistance. As expected, macrophages in adipose 
tissue from HFD-fed BMT-Per1ldc/Per2ldc mice exhibited more proinflammatory 
properties, compared to HFD-fed BMT-WT mice, resulting in exacerbated adipose 
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tissue inflammation and insulin resistance. Significantly, increased severity of systemic 
insulin resistance was observed in BMT-Per1ldc/Per2ldc mice after HFD feeding. Lastly, 
in vitro co-culture study was conducted to confirm the direct effect of macrophage 
Per1/Per2 disruption on increasing adipose tissue inflammation and insulin resistance. 
The study about the role of PFKFB3 on macrophage activation was conducted 
similarly as above. Decreased glycolysis and increased inflammatory responses were 
observed in BMDM when PFKFB3 was disrupted. Additionally, it was shown that 
PFKFB3 disruption in macrophages is sufficient enough to bring about systemic insulin 
resistance using BMT mouse model. As indicated by the results from co-culture 
experiments, PFKFB3-disrupted macrophages can directly increase adipocyte 
inflammatory responses and disturb insulin signaling. 
Taken together, either circadian dysregulation by disruption of clock genes Per1 
and Per2, or PFKFB3 disruption can exacerbate macrophage proinflammatory 
activation, resulting in severe diet-induced adipose tissue inflammation and systemic 
insulin resistance. 
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4.2 Conclusion 
The present study provided further evidence for the importance of macrophage 
inflammatory status in regulating adipose tissue inflammation and systemic insulin 
sensitivity in diet-induce obesity. This is supported by the findings that HFD-fed mice 
exhibited increased severity of adipose tissue inflammation and systemic insulin 
resistance, whenever macrophages were much more proinflammatory activated upon 
disruption of Per1/Per2 or PFKFB3. More importantly, this study gained new insights 
into the role of circadian and PFKFB3 in regulating macrophage activation status, which 
will promote the development of new evidence-based approaches for prevention and/or 
treatment of diet-induced systemic insulin resistance. 
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